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Abstract in English 
Background: Mental health and physical health are substantially associated with each other. The early 
recognition of co-occurring mental-physical conditions, as well as the early recognition of 
pathophysiological mechanisms underlying somatic symptoms, might be of special relevance for a 
better understanding of early phases of disorder development and hence prevention.  
 
Aim: To examine associations between symptoms of mental disorders (depressive symptoms and 
gambling behavior) and physical diseases, as well as associations between somatic symptoms and 
sensory responsiveness.  
 
Methods: We estimated (1) the association between depressive symptoms and physical diseases (N = 
14,348), (2) the association between gambling and physical diseases (N = 11,385), and (3) the 
association of sensory responsiveness with somatic symptoms and illness anxiety (N = 205). Logistic 
regression analyses were conducted to estimate the associations in studies (1) and (2). To estimate the 
associations in study (3) we conducted a linear multiple regression model. We controlled for potential 
confounders in all three studies. 
 
Results: (1) Depressive symptoms were associated with Arthrosis and Arthritis and any physical 
disease. (2) Gambling in the past 12 months was associated with Diabetes, Arthrosis and Arthritis, 
High blood pressure, allergies like Hay Fever, and any physical disease. (3) Increased sensory 
responsiveness was associated with increased scores of the overall illness anxiety scale and its 
constituent subscale disease conviction.  
 
Discussion: Symptoms of mental disorders were associated with physical diseases and increased 
sensory responsiveness was associated with illness anxiety. Scrutinizing these associations might 
contribute to a better understanding of mental-physical comorbidity and might therefore have 
implications for early recognition, treatment and health care policy.  
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Abstract in German 
Hintergrund: Psychische und körperliche Gesundheit sind stark miteinander verbunden. Die 
Früherkennung von gemeinsam auftretenden psychisch-körperlichen Erkrankungen, sowie 
somatischen Symptomen zugrundeliegenden pathophysiologischen Mechanismen, könnte zu einem 
besseren Verständnis der frühen Krankheitsentwicklung und somit der Prävention beitragen.  
 
Ziel: Untersuchung der Zusammenhänge zwischen Symptomen psychischer Störungen (depressive 
Symptome und Glücksspielverhalten) und körperlichen Erkrankungen, sowie der Zusammenhänge 
zwischen somatischen Symptomen und sensorischer Empfindlichkeit.  
 
Methode: Untersucht wurden die Assoziation zwischen (1) depressiven Symptomen und körperlichen 
Erkrankungen (N = 14,348), (2) Glücksspielverhalten und körperlichen Erkrankungen (N = 11,385), 
und (3) sensorischer Empfindlichkeit und somatischen Symptomen oder Krankheitsangst (N = 205). 
Assoziationen in Studie (1) und (2) wurden anhand logistischer Regressionen geschätzt. In Studie (3) 
wurde ein lineares multiples Regressionsmodells verwendet. Potenzielle Störvariablen wurden in allen 
drei Studien kontrolliert. 
 
Resultate: (1) Depressive Symptome waren mit Arthrose und Arthritis und irgendeiner körperlichen 
Erkrankung assoziiert. (2) Glücksspiele spielen in den letzten 12 Monaten war mit Diabetes, Arthrose 
und Arthritis, hohem Blutdruck, Allergien wie Heuschnupfen und irgendeiner körperlichen 
Erkrankung assoziiert. (3) Erhöhte sensorische Empfindlichkeit war mit höheren Werten auf der 
allgemeinen Krankheitsangstskala und der Unterskala Krankheitsüberzeugung assoziiert.  
 
Diskussion: Symptome psychischer Störungen waren assoziiert mit körperlichen Erkrankungen und 
erhöhte sensorische Empfindlichkeit war assoziiert mit Krankheitsangst. Die eingehende 
Untersuchung dieser Zusammenhänge könnte zu einem besseren Verständnis psychisch-körperlicher 
Komorbiditäten beitragen und somit Implikationen für die Früherkennung, Behandlung und 
Gesundheitspolitik haben.   
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„The greatest mistake in the treatment of diseases is that there are physicians for the body and 
physicians for the soul, although the two cannot be separated.” 
Plato (427–347 BC) 
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Introduction 
Why do people consult a doctor? One of the most common reasons for consultations in primary care is 
the presence of physical symptoms (Schappert, 1998). According to a study of primary care patients, 
15% of the physical symptoms have purely somatic causes (Kroenke & Mangelsdorff, 1989). 10% to 
15% of primary care patients report physical symptoms without clear somatic causes (Kroenke, 2003), 
and up to 20% of patients in primary care studies fulfill the diagnostic criteria for the mental disorder 
category of Somatoform Disorders (SD) according to the Diagnostic and Statistical Manual of Mental 
Disorders 4th edition (DSM-IV) (Körber, Frieser, Steinbrecher, & Hiller, 2011). Mental disorders are 
syndromes incorporating clinically relevant emotional, cognitive or behavioral dysfunction in 
individuals (American Psychiatric Association, 2013). Thereby, mental disorders lead to disability in 
different areas of life, such as social or professional functioning (American Psychiatric Association, 
2013). Mental Disorders often remain undetected and untreated in primary care as individuals 
suffering from symptoms of mental disorders may report multiple bodily symptoms (Cassano & Fava, 
2002). Although, not all individuals suffering from symptoms of mental disorders develop full blown 
clinical mental conditions, symptoms of mental disorders can lead to disability comparable with that 
seen in fully diagnosed mental disorders (Ayuso-Mateos, Nuevo, Verdes, Naidoo, & Chatterji, 2010; 
Haller, Cramer, Lauche, Gass, & Dobos, 2014; Lieb, Pfister, Mastaler, & Wittchen, 2000). 
 In this context, it is hardly surprising that population-based studies around the world 
revealed a frequent co-occurrence of mental disorders and non-communicable physical diseases (Scott 
et al., 2009; Von Korff, Scott, & Gureje, 2009). Physical diseases are also accompanied by behavioral, 
emotional and cognitive changes (World Health Organization, 2011, 2013). In general, patients 
suffering from physical diseases and comorbid mental disorders experience increased burden, 
impairment and decreased quality of life as compared to patients with physical diseases without 
comorbid mental disorders (Baumeister & Härter, 2005; Sareen, Cox, Clara, & Asmundson, 2005; 
Sareen et al., 2006; Sartorius, Holt, & Maj, 2015; Scott et al., 2009). Moreover, mental disorders co-
occurring with physical diseases are more difficult to detect than mental disorders occurring alone 
(Goldberg, 2010; Kapfhammer, 2015; Stark & House, 2000). Lack of an exact diagnosis makes it 
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difficult to choose the right therapy for patients, which might lead to a worse outcome of either of the 
comorbid conditions (Baumeister & Härter, 2005; Naylor et al., 2012). 
 Depression has frequently been associated with physical diseases (Patten et al., 2009; Patten 
et al., 2008). Moreover, it has been shown that even subthreshold depressive conditions can cause 
impairment comparable with that seen in full blown depressive conditions (Ayuso-Mateos et al., 2010; 
Kessing, 2007; Klein, Shankman, Lewinsohn, & Seeley, 2009). In addition, physical diseases have 
also been associated with other mental disorders, such as Anxiety Disorders (Kariuki-Nyuthe & Stein, 
2015; Roy-Byrne et al., 2008) and Gambling Disorder (American Psychiatric Association, 2013; 
Black, Shaw, McCormick, & Allen, 2013; Morasco, Pietrzak, et al., 2006), formerly referred to as 
Pathological Gambling and assigned to the category of Impulse Control Disorders Not Elsewhere 
Classified (American Psychiatric Association, 1994). Notably, Pathological Gambling deserves special 
attention because of the strong growth rate of the gambling industry, especially in the online sector 
(European Commission, 2012). Recent research has already shown that there is an association between 
Pathological Gambling and physical diseases (Black et al., 2013; Desai, Desai, & Potenza, 2007; 
Morasco, Pietrzak, et al., 2006; Pietrzak, Morasco, Blanco, Grant, & Petry, 2007). However, is not yet 
clear whether gambling behavior itself, as an important dimension of Gambling Disorder, is associated 
with physical diseases. 
 For the reasons mentioned above, it is essential to scrutinize mental-physical comorbidity 
patterns. An improved early assessment of unfavourable behavior and an early recognition of 
dimensions and symptoms of mental disorders could improve therapy for subjects with comorbid 
conditions. Findings on comorbidity might also reveal potential mechanisms in the etiopathogenesis of 
respective conditions. 
 As previously mentioned, apart from mental-physical comorbidity, there are disorders 
comprising mental and physical symptoms referred to as SD in the DSM-IV (American Psychiatric 
Association, 1994). This disorder category has been criticised over years (Kroenke, Sharpe, & Sykes, 
2007; Mayou, Kirmayer, Simon, Kroenke, & Sharpe, 2005; Rief & Isaac, 2007; Voigt et al., 2010), as 
it comprises subcategories with different key aspects, including the two main subcategories 
Somatization Disorder (key aspect: quantity of somatic symptoms) and Hypochondriasis (key aspect: 
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anxiety of having a serious disease). Despite the reconceptualised diagnostic criteria for SD within the 
new Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) category Somatic 
Symptom and Related Disorders (American Psychiatric Association, 2013), the etiology of SD is not 
yet fully established (Brown, 2004; Deary, Chalder, & Sharpe, 2007; Witthoft & Hiller, 2010). 
 Although the co-occurrence of mental disorders and physical diseases has been repeatedly 
demonstrated (Iacovides & Siamouli, 2008; Kolappa, Henderson, & Kishore, 2013; Leentjens, 2010; 
Olaya et al., 2012; Prince et al., 2007; Von Korff et al., 2009), factors underlying the mental-physical 
comorbidity are not clearly understood yet (Valderas, Starfield, Sibbald, Salisbury, & Roland, 2009; 
Von Korff et al., 2009).  
 Taken together, these highlights the importance of studying mental-physical comorbidity 
patterns, as respective findings may inform about the early recognition and underlying factors and of 
related clinical conditions. Moreover, this highlights the importance of conducting population-based 
studies and studies with non-clinical samples as these studies have the advantage of allowing to 
capture subclinical symptoms of mental disorders, which may be of special relevance for a better 
understanding of the early phases of disorder development and hence prevention. 
 
Scope of the Thesis 
As a part of the superior research field on associations between mental and physical health, the 
findings presented here address some of the above mentioned issues. The general scope of this thesis 
is to contribute to a better understanding of the comorbidity of symptoms of mental disorders and 
physical diseases, as well as a better understanding of the pathophysiology underlying Somatic 
Symptom and Related Disorders. In the present thesis a symptom of a mental disorder is referred to as 
a single criterion or component of a mental disorder.  
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 Objectives 
The presented thesis is based on three papers. The first two investigated the association between 
symptoms of mental disorders and physical diseases, including (1) depressive symptoms and physical 
diseases (depressive symptoms) and (2) gambling and physical diseases (gambling). The third study 
investigated the association between (3) illness anxiety, somatic symptoms and sensory responsiveness 
(somatic symptoms). Scrutinizing these associations could contribute to a better understanding of the 
early phases of disorder development and hence prevention.  
 
 Research Questions 
Based on previous research and the papers presented here this thesis addresses the following specific 
questions:  
(1) Depressive symptoms: Can previous findings on the associations between depressive symptoms 
and physical diseases be replicated? 
(2) Gambling: Is gambling behavior itself associated with physical diseases? 
(3) Somatic symptoms: Could sensory responsiveness as a biological correlate contribute to a better 
understanding of the pathophysiology underlying Somatic Symptom and Related Disorders? 
(4) Overall research question 1 (based on paper one depressive symptoms and paper two gambling): 
Are there similarities between mental-physical associations, with regard to physical diseases, in paper 
one and two? 
(5) Overall research question 2: Are different symptoms of mental disorders associated with physical 
diseases and physiological reactions? 
 
 Approach 
To answer the questions above the following approaches were used: 
(1) Depressive symptoms: The association between depressive symptoms and a wide range of physical 
diseases was estimated using data from a population-based survey. 
(2) Gambling: Data from the same population-based survey was used to evaluate the association 
between gambling and a wide range of physical diseases.  
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(3) Somatic symptoms: In a different non-clinical sample, the association between sensory 
responsiveness (measured via vibrotactile perception thresholds) and somatic symptoms, illness 
anxiety and trait anxiety was explored.  
(4) Overall research question 1: The findings from the depressive symptoms and gambling paper were 
summarized and compared.  
 (5) Overall research question 2: General integration of the findings derived from the three papers.  
 
Outline of the Thesis 
The structure of this thesis is as follows: The “Introduction” gave an overview of the relevance and 
scope of the research presented in this thesis. In the section “Theoretical Background” the theoretical 
background and current state of research with regard to mental disorders and symptoms of mental 
disorders, physical diseases and the comorbidity of mental disorders and physical diseases will be 
covered. The “Methods” briefly describe the methodology used for the designs, the collection of data 
and statistical analyses. The section “Results and Main Conclusions” summarizes the results of this 
thesis and condenses them into a main conclusion. Finally, the “General Discussion” will show 
implications derived from the here presented papers, including strengths and limitations of the three 
papers, and present an outlook for future research. A detailed description of the three presented 
scientific papers can be found in Appendix A to C.  
  
 From Mental-Physical Comorbidity to Somatic Symptoms 9 
Theoretical Background 
Overview of Selected Mental Disorders and Symptoms of Mental Disorders 
Mental disorders can lead to disability in different areas of life, such as social or professional 
functioning (American Psychiatric Association, 2013). They are syndromes incorporating clinically 
relevant emotional, cognitive or behavioral dysfunction in individuals (American Psychiatric 
Association, 2013). Mental disorders have a profound impact on the social and economic burden 
worldwide (Alonso et al., 2011; R. C. Kessler & Ustun, 2008). In Europe, an estimated 38.2% of the 
population suffers from a diagnosed mental disorder per year (Wittchen et al., 2011). Although, not all 
individuals suffering from symptoms of mental disorders develop full blown clinical mental 
conditions, individual symptoms of mental disorders, such as depressive symptoms not qualifying for 
a diagnosis, can lead to disability comparable with that seen in fully diagnosed Depressive Disorders 
(Ayuso-Mateos et al., 2010). Epidemiological studies revealed that mental disorders – including 
anxiety, mood and behavior disorders – manifest themselves mostly in the second and third decades of 
life (Merikangas et al., 2010; Wittchen, Nelson, & Lachner, 1998), whereby Anxiety Disorders show 
the earliest onset (Andrade et al., 2000).   
Current models of the etiology of mental disorders assume that an interplay of neurobiological, 
psychological and social factors (diathesis/vulnerability) together with stressors (such as critical life 
events) and modifying factors (such as natural resilience) accounts for the development of mental 
disorders (Wittchen & Hoyer, 2011). Further evidence suggests that modifiable unfavourable 
behaviour (also referred to as lifestyle factors), such as smoking, and physical inactivity, might as well 
play a crucial role in the development of mental disorders (Oldenburg, O`Neil, & Cocker, 2015).  
 The presence of subthreshold mental conditions (Ayuso-Mateos et al., 2010; Judd, Rapaport, 
Paulus, & Brown, 1994), as well as individual symptoms of mental disorders is widespread in the 
general population (Ayuso-Mateos et al., 2010; Wittchen, Lieb, Pfister, & Schuster, 2000). Therefore 
scrutinizing research on symptoms of mental disorders might improve our understanding of the 
pathogenesis and etiopathology of respective clinical conditions. 
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 Depressive Disorders  
Depressive Disorders are characterized by the feeling of sadness, emptiness or irritable mood and 
involve somatic and cognitive changes (American Psychiatric Association, 2013). According to the 
World Health Organization (WHO), around 350 million people suffer from depression worldwide 
(World Health Organization, 2012). Depressive Disorders cause substantial impairment, decrease 
quality of life and increase mortality (Culpepper, 2011), which makes them one of the greatest 
contributors to the global disease burden (Ferrari et al., 2013; Wittchen et al., 2011). Additionally, 
Depressive Disorders are highly comorbid with other mental disorders, somatic symptoms and pain 
(Lieb, Mastaler, & Wittchen, 1999). Moreover, subthreshold depressive conditions can cause 
impairment comparable with that seen in full blown Depressive Disorders (Ayuso-Mateos et al., 2010; 
Kessing, 2007; Klein et al., 2009). Thus, even individual depressive symptoms can cause substantial 
distress and lead to significant impairment in everyday functioning (Ayuso-Mateos et al., 2010). 
Moreover, primary care studies revealed that individuals with depressive conditions more frequently 
report physical health problems than mentally healthy individuals (Smith et al., 2014). Although 
depressive symptoms are common in primary care patients (Pieper, Schulz, Klotsche, Eichler, & 
Wittchen, 2008), they often remain unrecognized and untreated (Cassano & Fava, 2002). In this 
context, especially the co-occurrence of depressive symptoms and physical diseases poses great 
challenges for health care and prevention (Sartorious, 2013; Sartorius et al., 2015; Smith et al., 2014).  
 
 Gambling Disorder  
Gambling Disorder, the only non-substance-related addictive disorder included in the DSM-5, 
formerly known as Pathological Gambling, is characterized by constant and recurring problematic 
gambling behavior (American Psychiatric Association, 2013). This leads to clinically significant 
impairment or distress, such as the need to gamble for increasing stakes in order to experience the 
desired excitement, or restlessness or irritability when trying to reduce the time spent gambling 
(American Psychiatric Association, 2013). More specifically, pathological gambling has been 
associated with lower social functioning (Bergh & Kuhlhorn, 1994), lower physical activity and 
obesity (Black et al., 2013), and affective and substance use disorders (Dowling et al., 2015; El-
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Guebaly et al., 2006; Lorains, Cowlishaw, & Thomas, 2011) resulting in poorer psychosocial well-
being (Bergh & Kuhlhorn, 1994) and poorer general physical health due to the excessive amounts of 
time spent pursuing this activity (Erickson, Molina, Ladd, Pietrzak, & Petry, 2005; Morasco, Eigen, & 
Petry, 2006). Evidence suggests associations between pathological gambling and a variety of physical 
diseases (Black et al., 2013; Desai et al., 2007; Morasco, Pietrzak, et al., 2006; Pietrzak et al., 2007). 
However, findings on the associations between pathological gambling and physical diseases are 
largely based on data from the U.S. National Epidemiologic Survey on Alcohol and Related 
Conditions and therefore studies replicating these results are highly warranted. Moreover, and if 
compared to other smaller studies, the findings remain heterogeneous due to the different criteria and 
thresholds for pathological gambling, as well as assessment instruments used to assess gambling 
behavior. It is not yet known whether gambling behavior itself, as an important dimension of 
Gambling Disorder, is associated with physical diseases. However, further research, especially 
regarding possible correlates of gambling behavior, is highly warranted.  
 
 Somatic Symptom and Related Disorders 
In the course of the DSM-5 development, SD (DSM-IV) have been reconceptualized as Somatic 
Symptom and Related Disorders, with a stronger emphasis on a subjects thoughts and feelings 
(American Psychiatric Association, 2013). Up to 20% of patients in primary care studies fulfill the 
diagnostic criteria for SD according to DSM-IV (Körber et al., 2011). Annually, an estimated 4.9% of 
the European population suffers from SD (Wittchen et al., 2011). These disorders include somatic 
symptoms in association with high distress and impairment (American Psychiatric Association, 1994) 
comparable with that seen in Depressive and Anxiety Disorders (De Waal, Arnold, Eekhof, & Van 
Hemert, 2004; Kroenke et al., 1997). Even somatic symptoms not qualifying for a diagnosis of SD 
cause substantial impairment and may pave the way for the development of other mental disorders 
(Lieb et al., 2000). Moreover, SD often co-occur with Anxiety and Depressive disorders, but the 
underlying factors of this comorbidity remain elusive (Lieb, Meinlschmidt, & Araya, 2007). 
 The DSM-IV diagnostic category of SD is an accumulation of disorders with different symptom 
clusters, mainly defined by somatic symptoms (American Psychiatric Association, 1994). The two 
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main DSM-IV categories of SD comprise Somatization Disorder (key aspect: quantity of somatic 
symptoms) and Hypochondriasis (key aspect: anxiety of having a serious disease) (American 
Psychiatric Association, 1994). The latter diagnosis, Hypochondriasis, has been discussed repeatedly 
(Noyes, Stuart, Watson, & Langbehn, 2006), as its key aspect “anxiety of having a serious disease” 
suggests an overlap with other Anxiety Disorders. Therefore, it could be argued that Hypochondriasis 
belongs to the group of Anxiety Disorders (Noyes, 1999; Olatunji, Deacon, & Abramowitz, 2009).  
 In this context, evidence suggests that Somatosensory Amplification (Barsky, Wyshak, & 
Klerman, 1990) might play a crucial role in the etiology of all DSM-IV SD (Brown, 2004; Deary et 
al., 2007; Witthoft & Hiller, 2010). Somatosensory Amplification is the exaggerated perception of 
bodily sensations and their attribution to disease (Barsky et al., 1990). However, despite the DSM-5 
reconceptualization of SD it remains unclear, whether the etiology of these disorders includes truly 
altered physiological sensitivity to sensory input and not merely subjective exaggerated perception of 
bodily sensations (Brown, 2004; Deary et al., 2007; Witthoft & Hiller, 2010).  
 
Physical Diseases 
Non-communicable physical diseases are chronic medical conditions which are non-transmissible 
between individuals (World Health Organization, 2013). The most common non-communicable 
physical diseases are Cardiovascular Diseases, Cancer, Chronic Respiratory Disease and Diabetes 
(World Health Organization, 2011, 2013). The WHO reports that non-communicable diseases, such as 
Diabetes and Cardiovascular Diseases, account for the highest proportion of burden and disability 
worldwide, leading to more than 36 million people dying from these diseases annually (World Health 
Organization, 2013). Physical diseases share common traits, including a long etiopathology and slow 
progression of symptoms (World Health Organization, 2013). Moreover, they also have multiple 
common behavioral risk factors, including unhealthy lifestyle, excessive tobacco use or physical 
inactivity and are accompanied by behavioral, emotional and cognitive changes (World Health 
Organization, 2011, 2013). Summarized, the above highlights the importance of scrutinizing mental 
correlates of physical diseases. 
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Comorbidity of Mental Disorders and Physical Diseases 
Comorbidity is defined as the co-occurrence of more than one distinct mental or physical disorder in 
one person in a defined time interval (Feinstein, 1970; Lieb, Schreier, & Müller, 2003; Valderas et al., 
2009; Wittchen & Hoyer, 2011). Evidence shows that comorbidity is common between all types of 
disease, whether mental or physical (mental-mental, physical-physical, mental-physical) (Von Korff et 
al., 2009; Wittchen & Hoyer, 2011). Especially the comorbidity of mental disorders with physical 
diseases poses great demands on health care, as comorbid conditions decrease the quality of life, 
prolong illness duration and lead to worse health outcomes (Kolappa et al., 2013; Sartorious, 2013; 
Sartorius et al., 2015). These circumstances increase the economic burden to society due to increased 
health care use and a loss of productivity (Sartorius et al., 2015).  
 Notably, mental disorders are more common in patients with physical diseases than in the 
general population (Clarke & Currie, 2009). Comorbidity has a huge impact on role disability 
(Merikangas et al., 2007) and patients suffering from physical diseases and comorbid mental disorders 
show increased mortality rates and decreased quality of life as compared to patients with physical 
diseases without comorbid mental disorders (Baumeister, Balke, & Harter, 2005). According to a 
cross-sectional population-based study, individuals with Depressive Disorders and comorbid physical 
disease report greater disability and increased healthcare-utilization than individuals without comorbid 
Depressive Disorders (Stein, Cox, Afifi, Belik, & Sareen, 2006). Population-based studies found 
similar patterns for people suffering from individual symptoms of mental disorders, such as depressive 
symptoms: increased rates of a wide range of physical diseases and impairment comparable to that 
seen in fully diagnosed patients (Von Korff et al., 2009). Moreover, the comorbidity of mental 
disorders and physical diseases is regarded as an important factor within the estimation of health care 
costs (Gustavsson et al., 2011), since individuals with comorbid conditions generate much higher 
health care costs than individuals with single mental disorders or physical diseases (Hochlehnert et al., 
2011; Hutter, Schnurr, & Baumeister, 2010; Mc Daid & Park, 2015; Unutzer et al., 2009).  
 Until now, the etiology of mental-physical comorbidity is not yet fully understood (Von Korff 
et al., 2009). Härter, Baumeister, and Bengel (2007) propose five different simplified models for the 
association between mental disorders and physical diseases. Figure 1 illustrates the proposed models. 
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The first model assumes that on a bio-physiological level a physical disease (or corresponding medical 
treatment) might cause a mental disorder. For example it has been shown that the hypofunction of the 
thyroid can trigger depressive symptoms (Chakrabarti, 2011). The second model proposes that within 
genetically vulnerable individuals the onset of a physical disease might precede the onset of a mental 
disorder. Cushing`s disease, a disease of the pituitary gland, for example, might precede Major 
Depression episodes (Sonino & Fava, 1998). Within the third model a mental disorder might emerge 
as a reaction to a physical disease (or corresponding medical treatment). Thus, Cancer patients 
frequently suffer from mood disorders (Mitchell et al., 2011). Model four assumes that a mental 
disorder precedes the onset of a physical disease (or symptom) or may have an adverse impact on the 
respective disease. For example, an untreated Depressive Disorder together with acute back pain might 
lead to chronic back pain (Larson, Clark, & Eaton, 2004). In this context, different studies even 
suggest that Depressive Disorders might be a risk factor for mortality in patients with Coronary Heart 
Disease (Barth, Schumacher, & Herrmann-Lingen, 2004; Vieweg et al., 2006). In the fifth model, 
Härter et al. (2007) suggest that the comorbidity of mental and physical diseases is coincidental: 
Posttraumatic Stress Disorder, for example, together with Rheumatoid Arthritis. Additionally, there is 
growing evidence that unfavourable behaviour, including smoking, physical inactivity and unhealthy 
diet, might represent risk factors for both non-communicable physical diseases and mental disorders 
(Oldenburg et al., 2015).  
 
 
Figure 1. Simplified models for the association between mental disorders and physical diseases. 
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 Previous studies showed strong associations between Depressive Disorders and 
Cardiovascular Diseases (Hesslinger et al., 2002), Diabetes (Anderson, Freedland, Clouse, & Lustman, 
2001; Härter & Berger, 2000), Chronic Obstructive Pulmonary Disease (Mikkelsen, Middelboe, 
Pisinger, & Stage, 2004), and Chronic Musculoskeletal Disorders (Dickens, McGowan, Clark-Carter, 
& Creed, 2002; Rosemann et al., 2007). However, findings on the direction of the respective 
associations remain heterogeneous (Härter et al., 2007; Katon, 2011; Mezuk, Eaton, Albrecht, & 
Golden, 2008; Wagner, Icks, Albers, & Abholz, 2012). Until now, the factors underlying mental and 
physical comorbidity are still not fully understood (Härter et al., 2007).  
 Taken together, findings on mental-physical comorbidity patterns might inform about 
potential mechanisms underlying the etiology of respective disorders.  
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Methods 
This section gives an overview on study design, sample and methods applied in the three papers. A 
detailed description for each study is given in the respective paper, which can be found in Appendices 
A to C. All studies applied a cross-sectional study design. All tests were two-tailed with a significance 
level of 0.05. 
 
Depressive Symptoms  
The sample (N = 14,348) of the depressive symptoms paper consisted of participants of the Swiss 
Health Survey (SHS) conducted in Switzerland in 2007. This periodic population-based survey 
includes, amongst others, data on depressive symptoms and a wide range of physical diseases. 
Depressive symptoms were assessed with the screening scale for depression from the World Health 
Organization Composite International Diagnostic Interview Short Form (R. C. Kessler, Andrews, G., 
Mroczek, D., Ustun, B., & Wittchen, H. U., 1998) and physical diseases were assessed with a self-
report checklist based on the European Health Interview Survey (Eurostat Working Group on Public 
Health Statistics, 2006). To estimate the associations between depressive symptoms and different 
physical diseases we applied logistic regression models and controlled for multiple testing using the 
Holm-Bonferroni method (Holm, 1979). We adjusted the same models for age, sex, education, 
occupation and equivalised household income.  
 
Gambling 
Participants of the Swiss Health Survey 2007, a periodic and population-based survey conducted in 
Switzerland, make up the sample of the gambling paper (N = 11,385). Amongst others, this Swiss 
Health Survey includes data on gambling and a wide range of physical diseases. In the SHS; gambling 
was assessed with self-report questions on gambling behavior with the following two questions: “Have 
you ever played games of chance in your lifetime?” and “Have you played games of chance in the past 
12 months?”. Physical diseases were assessed with a self-report checklist based on the European 
Health Interview Survey (Eurostat Working Group on Public Health Statistics, 2006). We examined 
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the associations between gambling and the presence/absence of physical diseases in the past 12 
months applying separate logistic regression models. Gambling versus not gambling in the past 12 
months was used as predictor. Adjustment was made for age, sex, education, occupation and 
equivalised household income.  
 
Somatic Symptoms 
The non-clinical sample (N = 205) of the somatic symptoms study consisted of participants recruited 
by advertisements on the web page of the University of Basel and the study database of the 
Department of Psychology in Basel, Switzerland. All participants underwent a single individual 
session including standardized questionnaires and different physiological measurements. Sensory 
responsiveness was assessed on the fingertip via vibrotactile perception thresholds using the HVLab 
Vibrotactile Perception Meter (Institute of Sound and Vibration Research, University of Southampton, 
United Kingdom). Somatic symptoms were assessed with a Screening for Somatoform Symptoms 
(Rief, Hiller, & Heuser, 1997). Illness anxiety was assessed with a self-rating questionnaire (overall 
sum score for illness anxiety and the scores for the three subscales disease phobia, bodily 
preoccupation and disease conviction (Hiller & Rief, 2004) and trait anxiety were assessed with a self-
rating scale (Laux, Glanzmann, Schaffner, & Spielberger, 1981). We examined the association 
between sensory responsiveness and somatic symptoms, illness anxiety and trait anxiety using a linear 
multiple regression model and nonparametric unconditional bootstrapping (Canty & Ripley, 2011; 
Davison & Hinkley, 1997; Harrell, 2001). We adjusted the same model for age, sex and 
socioeconomic status.  
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Results and Main Conclusions 
This section provides a brief summary of the results and the main conclusions drawn in the three 
research papers. For more detailed information on the results, see Appendices A to C.  
 
Depressive Symptoms 
The presence of depressive symptoms was associated with any physical disease. More specifically, 
depressive symptoms were related to an increased risk for Arthrosis and Arthritis. Thus, we were able 
to replicate previous findings on the associations between depressive symptoms and physical diseases 
in general (Chapman, Perry, & Strine, 2005; Clarke & Currie, 2009; Evans et al., 2005; Klesse, 
Baumeister, Bengel, & Härter, 2008) and associations between depression and Arthrosis and Arthritis 
in specific (Dickens et al., 2002; Dobkin, Filipski, Looper, Schieir, & Baron, 2008; Looper et al., 
2011). The finding that depressive symptoms were related to Arthrosis and Arthritis might have 
implications for clinical practice, such as screening subjects with Arthrosis and Arthritis for depressive 
symptoms and vice versa. Early recognition of the co-occurrence of depressive symptoms with 
Arthrosis or Arthritis might allow for an improved coordination of interdisciplinary treatment. This 
may positively influence the course of both conditions. Moreover, our results might have implications 
for more precise future estimates of costs related to depression and, by accounting for co-occurrence 
of comorbid conditions, might contribute to more precise future estimates for costs of co-occurring 
depressive symptoms and physical diseases. 
 
Gambling 
In this paper, we estimated an association between gambling behavior in the past 12 months and an 
increased risk of Diabetes, Arthrosis and Arthritis, High Blood Pressure, allergies like Hay Fever, and 
any physical disease in the past 12 months. Our findings might point to the importance of the early 
assessment of gambling behavior in general and might have implications for the prevention of physical 
diseases in gamblers through the assessment of gambling behavior and associated risk-factors. 
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Moreover, early recognition of pathological gambling and associated risk-factors as well as physical 
conditions, might assist in the reduction of the costs to the health care system.  
 
Somatic Symptoms 
We estimated an association between increased illness anxiety and higher sensory responsiveness in 
general and an association between disease conviction and higher sensory responsiveness in particular. 
Somatic symptoms and trait anxiety were not associated with sensory responsiveness. These findings 
suggest that the pathophysiological mechanisms underlying illness anxiety might be different from 
those underlying other somatic symptoms. Our results may have the potential to contribute to a better 
understanding of pathophysiological mechanisms in Illness Anxiety Disorder and might therefore 
improve the classification and treatment of Somatic Symptom and Related Disorders.  
 
Overall Research Question 1 
The overall research question 1 was whether there were similarities between mental-physical 
associations, with regard to physical diseases, in the papers one (depressive symptoms) and two 
(gambling). In the gambling paper some of the disease categories were excluded from the analyses 
(too small number of subjects reporting respective conditions), thus Table 1 only summarizes the 
associations of the included disease categories in the gambling paper. Although the methods of the two 
papers are not completely comparable, especially regarding the different mental components 
depressive symptoms and gambling, and the control for multiple testing in the depressive symptoms 
paper, the results show comparable associations (Table 1). The associations estimated in both papers 
might point to a shared etiology of mental and physical conditions. Moreover, the estimated 
associations might suggest common risk factors for mental and physical conditions.  
However, these conclusions are purely speculative and should be scrutinized in future studies. 
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Overall Research Question 2 
The overall research question 2 was whether different symptoms of mental disorders were associated 
with physical diseases and physiological reactions. In general, we clearly showed that there is a 
substantial association between symptoms of mental disorders and physical diseases in the depressive 
symptoms and gambling paper. Additionally, in the somatic symptoms paper we were able to show that 
illness anxiety, as a symptom of a mental disorder, is associated with increased sensory 
responsiveness, a physiological reaction. If the estimated associations in all papers prove to be causal, 
one may speculate that the detection of mere symptoms, in contrast to full blown clinical conditions, 
might allow for the prevention of related clinical disorders. 
  
TABLE 1. Summary of the associations. 
 Depressive symptoms  Gambling 
Physical diseases Crude
a 
Adjusted
b 
Crude Adjusted 
Any physical disease     
Asthma     
Diabetes  ()   
Arthrosis, Arthritis ()    
High Blood Pressure     
Allergies, Hay Fever () ()   
a
Unadjusted for covariates. 
b
Adjusted for age, sex, education, occupation, and household income. 
 = significant association, () = association not significant after controlling for multiple testing,  = not 
significant association.  
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General Discussion 
The aim of the three research papers presented within this thesis was to investigate different aspects of 
the association between symptoms of mental disorders and physical diseases, as well as the association 
between illness anxiety, somatic symptoms and sensory responsiveness. Two papers (depressive 
symptoms and gambling) investigated the association between symptoms of mental disorders and 
physical diseases. First, depressive symptoms were associated with an increased risk for any physical 
disease; specifically depressive symptoms were related to an increased risk for Arthrosis and Arthritis. 
Second, gambling in the past 12 months was associated with an increased risk of Diabetes, Arthrosis 
and Arthritis, High Blood Pressure, allergies like Hay Fever, and any physical disease. The third paper 
(somatic symptoms) explored, whether sensory responsiveness could contribute to a better 
understanding of pathophysiological mechanisms underlying somatic symptoms and illness anxiety: 
whereas increased illness anxiety in general and disease conviction in particular were associated with 
higher sensory responsiveness, neither somatic symptoms nor trait anxiety were associated with 
sensory responsiveness.  
 
General Implications 
The here presented findings have the potential to contribute to a better understanding of associations 
between mental and physical conditions. Moreover, findings on comorbidity patterns could provide a 
basis for hypotheses about the etiology of the comorbid conditions. As the implications of the specific 
findings have been discussed in the respective papers in the Appendices A to C, this chapter will 
provide possible comprehensive implications for early recognition, treatment and health care policy.  
 
 Implications for Early Recognition  
The findings presented here confirm the importance of properly identifying comorbid conditions, since 
many mental disorders and physical diseases share comparable symptoms (Goldberg, 2010; 
Kapfhammer, 2015). This makes the recognition of comorbid conditions extremely difficult 
(Goldberg, 2010; Kapfhammer, 2015; Stark & House, 2000). As symptoms of mental disorders are 
common in the general population and strongly associated with physical diseases (Von Korff et al., 
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2009), the detection of symptoms of mental disorders and associated risk-factors as well as physical 
conditions should be improved in general. Subjects with physical disorders should be screened for 
symptoms of mental disorders and vice versa. Additionally, the assessment of vibrotactile perception 
thresholds could be used as a new technique to differentiate between subtle somatic symptoms at an 
early stage of disorder development, especially with regard to illness anxiety. Not only do our results 
imply that it is important to screen subjects for common symptoms of mental disorders, such as 
depressive symptoms, but also they point to the need for recognising unfavourable behavioral patterns, 
such as excessive gambling. The latter has also been shown to have a negative impact on physical 
health (Erickson et al., 2005; Morasco, Eigen, et al., 2006). The early recognition of symptoms of 
mental disorders or physical diseases could improve the course of the emerging condition, as well as 
the comorbid disorder.  
 
 Implications for Treatment 
Early recognition of the co-occurrence of mental and physical conditions might allow for an improved 
coordination of interdisciplinary treatment, which may in turn positively influence the course of both 
mental and physical conditions. Previous studies showed that if there is an association between mental 
and physical conditions, failing to treat one condition correctly negatively impacts the other 
(Hochlehnert et al., 2011; Kolappa et al., 2013). This point to the importance of an early and correct 
detection of comorbid conditions, allowing for optimized treatment. It could be argued that another 
aspect of optimizing treatment for comorbid conditions is the detection of risk factors: for example, 
physical inactivity is a well-known risk factor for physical diseases (World Health Organization, 
2011). Physical inactivity is however also a symptom of Depressive and other mental disorders 
(American Psychiatric Association, 2013). Therefore, taking physical activity into account for the 
comprehensive treatment of comorbid conditions might positively influence the course and outcome of 
either one or both conditions.  
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 Implications for Health Care Policy 
An increase in the prevalence of comorbid mental-physical conditions is expected due to the 
worldwide demographic development (Sartorious, 2013; Sartorius et al., 2015). Unrecognized 
comorbid conditions already pose a substantial financial burden on health care systems (Mc Daid & 
Park, 2015). Moreover, it has been shown that symptoms of mental disorders cause substantial distress 
and impairment comparable with that seen in full blown mental conditions (Ayuso-Mateos et al., 
2010; Haller et al., 2014; Lieb et al., 2000). The presence of symptoms of mental disorders in subjects 
with a physical disease increases treatment costs for this disease, as compared to subjects without 
symptoms of mental disorders suffering from the same physical disease (Hochlehnert et al., 2011; 
Hutter et al., 2010; Iacovides & Siamouli, 2008; Unutzer et al., 2009). Thus, the costs to the health 
care system could be reduced through early recognition of comorbid conditions (Mc Daid & Park, 
2015). Therefore, changes to the health care system reflecting the reality of comorbid conditions are 
highly warranted. However, it is not yet clear how these changes will affect the financial aspect of 
future health care policies.  
 
General Strengths and Limitations 
The presented studies have several general strengths and limitations. Details on the strengths and 
limitations of the individual studies can be found in Appendices A to C.  
 
 General Strengths 
 Sample: All three studies included non-clinical samples, two included large representative 
population-based samples, one included young adults (mainly university students). Findings 
on an early stage of disorder development, in terms of symptoms and not fully blown clinical 
conditions, may have implications for the early recognition and treatment of respective clinical 
conditions.  
 Mental-physical comorbidity patterns: In the depressive symptoms paper previous findings 
were replicated in a large representative nation-wide sample in the context of a small high-
income country. The gambling study has the potential to contribute to a better understanding 
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of correlates of gambling behavior itself. In general, findings on comorbidity patterns could 
provide a basis for hypotheses about the etiology of the comorbid conditions. 
 Vibrotactile perception thresholds: The assessment of sensory responsiveness via vibrotactile 
perception thresholds in the context of the somatic symptoms study is highly innovative and 
may contribute to an optimized classification and treatment of Somatic Symptom and Related 
Disorders.  
 Statistical analyses: In all three studies potential socio-demographic confounders, which have 
previously been linked to the respective predictors and outcomes, were controlled.  
 
 General Limitations 
 Sample: The number of subjects suffering from some physical diseases, especially with regard 
to the two population-based studies, was relatively small. Moreover, all three studies 
contained non-clinical samples (two samples were population-based and one mainly contained 
university students), which might have led to an underestimation of present symptoms. Thus, 
small effects might not have been statistically detected due to a lack of statistical power. 
However, it can be assumed that there was enough variance in the respective samples, but the 
results should be replicated in sufficiently large clinical samples. 
 Response rate: The two population-based studies had a high non-response rate, which might 
have caused a selection bias (Volken, 2013). Therefore studies aiming to achieve a higher 
response rate are needed.  
 Study design: The cross-sectional study design of all three studies does not allow for 
conclusions about the causality of the estimated associations. Therefore we can only speculate 
about the possible explanations for the estimated associations and their direction.  
 Assessment of symptoms of mental disorders: Some symptoms may not have entered the 
studies because of the used screenings and the above mentioned sample composition. The 
somatic symptoms study included one screening which required confirmation of medical 
consultations for positive screening outcome. As the sample included mainly university 
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students, this screening most likely led to underestimation of respective symptoms, as the 
participants reported not to seek medical help due to financial reasons and/or a lack of time.  
 Generalizability: With regard to generalizability of the findings, caution is warranted. First, 
data from the depressive symptoms paper derived from a population with high-income, above 
average standard of living and a high preforming health care system. Thus, it is questionable 
whether the findings apply to other countries. Second, in the gambling paper gambling 
behavior itself and not pathological gambling was assessed. Therefore, caution is warranted 
with regard to generalizability of the findings to pathological gambling. Third, the somatic 
symptom study included a high functioning sample of volunteers (mainly university students) 
and the results are therefore not generalizable to other samples.  
 
Outlook 
There is a need for prospective, longitudinal studies with representative samples in the field of 
comorbidity research. Previous studies have demonstrated an association between mental disorders 
and physical diseases repeatedly (Von Korff et al., 2009). Current theoretical models on the etiology 
of mental-physical comorbidity are based on the assumptions that the link between mental disorders 
and physical disease is unidirectional, bidirectional, or results from underlying risk factors common to 
both conditions (Oldenburg et al., 2015; Von Korff et al., 2009). Thus, future research should focus on 
the strength, direction and underlying risk factors of mental-physical comorbidity. Moreover, in order 
to identify underlying mechanisms in the pathogenesis of comorbid conditions, changes of 
comorbidity patterns over time need to be assessed in future studies. In this context, special attention 
should be paid to unfavourable behavioral patterns (such as physical inactivity) as the characteristics 
of these patterns coincide with symptoms of common mental disorders and represent risk factors for 
physical diseases.  
 With regard to the somatic symptoms study future studies should focus on the 
pathophysiological mechanisms underlying illness anxiety. In this context, it would be interesting to 
replicate our findings in clinical samples and to evaluate if the measurement of vibrotactile perception 
thresholds represents a valid screening method for Illness Anxiety Disorder. 
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Overall Conclusion 
The papers investigating depressive symptoms and physical diseases (depressive symptoms), and 
gambling and physical diseases (gambling) showed that different psychological components – the 
affective component in the depressive symptoms paper and the behavioral in the gambling paper – are 
associated with physical diseases. This not only confirms previous findings on general mental-physical 
associations, but also expands findings by a behavioral component. In the light of social and economic 
changes, unhealthy lifestyles choices have reached epidemic proportions (World Health Organization, 
2009). This fact together with current evidence on behavioral risk factors common to mental disorders 
and physical diseases (Oldenburg et al., 2015; Von Korff et al., 2009), calls for integrative prevention 
strategies for mental and physical health (Hosman, 2015; Kolappa et al., 2013; Prince et al., 2007). 
Additionally, the results from the investigations on somatic symptoms highlight that the measurement 
of vibrotactile perception thresholds, if confirmed in other studies and in association with other 
symptoms of mental disorders, might contribute to the development of new physiological screening 
methods for mental disorders.  
 Taken together, a better understanding of the associations between mental and physical 
conditions, as well as a better understanding of factors underlying these associations, allows for the 
conception of new strategies for early recognition, treatment and health care policy. The insights 
gained from this research might help us to overcome the traditional gap between medicine of the body 
and medicine of the mind.  
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Objective: To estimate the association between depressive symptoms and physical dis-
eases in Switzerland, as respective findings might inform about future estimates of mental
and physical health care costs.
Methods:A population-based study, using data from the Swiss Health Survey collected by
computer-assisted telephone interviews and additional written questionnaires during the
year 2007 (n=18,760) in Switzerland. The multistage stratified random sample included
subjects aged 15 years and older, living in a private Swiss household with a telephone con-
nection. Complete data were available for 14,348 subjects (51% of all subjects reached by
telephone). Logistic regression analyses were used to estimate the associations between
depressive symptoms and any physical disease, or a specific physical disease out of 13 non-
communicable physical diseases assessed with a self-report checklist on common physical
diseases. Analyses were adjusted for sex, age, education, occupation, and household
income.
Results: In the adjusted models, depressive symptoms were associated with arthrosis and
arthritis [Odds Ratio (OR)=1.79, 95% confidence interval (CI)=1.28-2.50] and any physical
disease (OR=1.67, 95% CI=1.33-2.10) after controlling for multiple testing.
Conclusion:Our findings contribute to a better understanding of the comorbidity of depres-
sive symptoms and arthrosis and arthritis in Switzerland and might have implications for
more precise future estimates of mental and physical health care costs.
Keywords: comorbidity, co-occurrence, depressive symptoms,major depression,mental–physical,mental–somatic,
physical disease
INTRODUCTION
Depression is a global leading cause of disability (1–3), affecting
350 million people worldwide (4). According to the World Health
Organization, annually more than 36 million people die of non-
communicable physical diseases worldwide (5). Population-based
studies around the world revealed that the presence of depres-
sive symptoms is strongly associated with the presence of a wide
range of physical diseases (6). This association has especially been
reported in subjects with migraine (7, 8), asthma (7), diabetes (9,
10), chronic musculoskeletal disorders (11, 12), such as rheuma-
toid arthritis (13), stomach and duodenal ulcer (14), osteoporosis
(15), chronic obstructive pulmonary disease (COPD) (16, 17),
cardiovascular diseases (18), high blood pressure (19), myocar-
dial infarction (20), apoplexy (21), renal disease and calculi (22),
cancer (23), and allergies (24). Previous research showed that
depression is associated with a wide range of physical diseases
with the strongest association being reported with cardiovascular
Abbreviations: CI, confidence interval; CIDI-SF, Composite International Diagnos-
tic Interview Short Form; COPD, chronic obstructive pulmonary disease; OR, odds
ratio; SHS, Swiss health survey.
diseases (18), diabetes (9, 10), COPD (16), and chronic muscu-
loskeletal disorders (11, 12). However, findings on the direction of
the respective associations remain heterogeneous (25–28).
While there are a couple of studies, which assessed the patterns
of depressive symptoms and physical diseases in large (>10,000
participants) samples (6, 7, 29–31), the majority of studies com-
prised much smaller samples (e.g., in the field of depression and
arthrosis and arthritis 13). Therefore, high quality replication
studies, assessing depression in large representative nation-wide
samples are highly warranted.
While these findings cover the situation in a broad number of
low-, middle-, and large high-income countries (6), less focus has
been spent on small high-income countries, such as Switzerland
(32). Switzerland ranks among the top three countries in overall
prosperity (33) and has one of the best and most expensive health
care systems worldwide (34). Therefore, it might be interesting
to examine whether previous findings on the association between
depression and physical diseases extend to Switzerland.
Furthermore, increased life expectancy together with an overall
increased average age, not only in Switzerland (34) but also in
most other regions of the world (5), is expected to result in higher
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prevalence of physical diseases (5, 35). At the same time, the preva-
lence of mental disorders within the working population is rising
in Switzerland (36). Unfortunately, we are not yet in a position to
estimate whether the comorbidity of chronic physical diseases and
depression is about to increase as well, as the pattern of comorbid-
ity has, to the best of our knowledge, not yet been determined in
Switzerland. Our study might lay the foundation for further stud-
ies assessing the changes of mental–physical comorbidity patterns
over time, as the present data derive from a nation-wide health
survey conducted every 5 years in Switzerland.
Evidence suggests that patients suffering from physical diseases
and comorbid mental disorders show increased mortality rates,
decreased quality of life, and poorer health care outcomes as com-
pared to patients with physical diseases without comorbid mental
disorders (37, 38). Thus, scrutinizing the associations between
mental disorders and physical diseases could provide implications
for improved health care for patients with comorbid mental and
physical conditions.
The presence of depressive symptoms in subjects with a physical
disease increases treatment costs for this disease, as compared to
subjects without depressive symptoms suffering from the same dis-
ease (39–41). To date, a potential effect of depression on treatment
costs for related physical diseases was not taken into account for
precise estimates of the economic burden caused by depression in
Switzerland (42). Thus, it is essential to estimate the prevalence of
conditions comorbid with depression, and this article might there-
fore contribute to more precise future estimates of costs related to
depression in Switzerland and comparable countries.
Additionally, to estimate the costs for co-occurring depressive
symptoms and physical diseases, it is important to not simply add
the separate costs related to depressive symptoms (costs related
to depression per person, multiplied by number of subjects with
depression) to the separate costs related to physical diseases (costs
related to physical disease, multiplied by number of subjects with
physical disease), which is referred to as double counting (1).
Thus, by accounting for co-occurrence of these conditions, double
counting can be avoided. Thereby, the estimation of the preva-
lence of comorbid conditions might contribute to more precise
future estimates of costs of co-occurring depressive symptoms
and physical diseases.
The aim of this article was to estimate the association between
depressive symptoms and physical disease in Switzerland.
MATERIALS AND METHODS
DESIGN AND SAMPLE
Data were drawn from the Swiss Health Survey (SHS) conducted
by the Swiss Federal Statistical Office and carried out by the M.I.S.-
Trend S.A Institute in Lausanne and Gümligen in 2007 (43). The
data collection and storage for the SHS do not require formal
approval by an ethical committee, as this data collection, prepa-
ration, and storage are specifically permitted under Swiss law and
participants could decline to participate or withdraw at any time
(SR 431.012.1; SR 431.112.1). The authors of this manuscript
were not involved in data collection. Anonymized data for fur-
ther analysis were obtained upon signing a data confidentiality
and privacy contract from the Swiss Federal Statistical Office upon
request.
The SHS is a periodic, nation-wide, and cross-sectional survey
consisting of a computer assisted telephone interview followed by
a written questionnaire. The multistage stratified random sam-
ple included subjects aged 15 years and older, living in a private
Swiss household with a telephone connection in 2007. Out of
the 30,179 randomly selected private households a total of 18,760
subjects completed the telephone interview, corresponding to a
response rate of 66% (Figure 1). The additional written ques-
tionnaire was completed by 77% (n= 14,348) of the interview
participants (Figure 1).
The SHS, among others, provides representative data on men-
tal and physical health and healthcare utilization (43). A detailed
description of the SHS methodology and sampling has been
described elsewhere (44) and descriptive results of the SHS have
been reported in the Swiss Health Observatory of 2013 (45).
ASSESSMENT OF DEPRESSIVE SYMPTOMS
Depressive symptoms were assessed with the screening scale for
depression (46) from the World Health Organization Compos-
ite International Diagnostic Interview Short Form (CIDI-SF) in
the SHS. Participants were asked whether they felt sad, blue, or
depressed for two or more weeks during the past 12 months, fol-
lowed by a series of questions on symptoms related to depression,
such as weight gain or loss. A summary score was calculated based
on the positive responses to these symptom-related questions
(range 0–7). Subjects scoring above a cut-off of three symptoms
were screened positive for major depression. A detailed descrip-
tion of the CIDI-SF scoring has been reported elsewhere (47). The
CIDI-SF has demonstrated good performance for depression in
large community samples (48–50). Moreover, the CIDI-SF screen-
ing scale for depression demonstrated good reliability and validity
in the SHS sample (51).
ASSESSMENT OF PHYSICAL DISEASES
In the SHS, common non-communicable physical diseases were
assessed with a self-report checklist, based on the European
Health Interview Survey (52). Participants were asked whether
they received recent (more than 12 months ago) or current (dur-
ing the past 12 months) treatment by a medical doctor for each
physical disease out of a list of 13 conditions. These conditions
included migraine, asthma, diabetes, arthrosis and arthritis, stom-
ach ulcer and duodenal ulcer, osteoporosis, COPD and emphy-
sema, high blood pressure, myocardial infarction, apoplexy, renal
disease and renal calculi, cancer and blastoma, and allergies like
hay fever. Comparable checklists have shown high accord with
medical records (53, 54) and better accuracy than consultation
rates in national studies (55).
ASSESSMENT OF SOCIO-DEMOGRAPHIC MEASURES
We considered sex, age, education, occupation, and equivalized
household income as covariates as these characteristics have previ-
ously been linked to depression (56–58) and physical diseases (59).
Age was treated as categorical variable grouped into six categories:
15–30, 31–40, 41–50, 51–60, 61–70, and 71 years and above. The
educational level comprised three categories: mandatory school,
secondary school, and university (60). Occupation was catego-
rized into the four categories middle/higher senior management,
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Randomly selected 
private households
(1 person per 
household)
n = 30,179 
Eligible for 
interview
n = 28,319 (94%)
Ineligible for interview
(Total 1,860; 6%)
Inac!ve telephone number n = 849
Invalid telephone number n = 1,011
Interviewed
n = 18,760 (66% of 
those eligible for 
interview)
Non-par!cipa!on
(Total 9559; 34% of those eligible for 
interview)
Unavailable n = 3,730
Refused to par!cipate n = 5,238
Stopped interview n = 138
Language diﬃcul!es n = 445
Data available for analyses
n = 14,348 (51% of those 
eligible) 
Missing data (Total 4,412; 24% of 
those interviewed)
Addi!onal ques!onnaire
not returned n = 4,328
Missing data n = 84
FIGURE 1 | Flowchart of study participants.
office employees/other non-manual professions, small business
owners/independent craftspeople, and workpeople, based on the
Erikson–Goldthrope–Portocarero classification of occupation (60,
61). The equivalized household income, a continuous index repre-
senting a gradient between low and high income, was calculated by
dividing the monthly household income by the weighted number
of person in the household, where a weight of 1.0 was set for the
first person over 15 years, 0.5 for each additional person, and 0.3
for each child under 15 years (60, 62).
STATISTICAL ANALYSES
The goal was to assess the relationship between depressive symp-
toms and various types of physical disease. We run 14 separate
logistic regression models (unadjusted models) with depressive
symptoms (yes/no) as predictor, and each of the 13 physical dis-
eases (yes/no) or all combined diseases (“any physical disease”;
yes/no) as outcomes. We additionally ran the same 14 models,
controlling for the following covariates: sex, age, education, occu-
pation, and equivalized household income (adjusted models).
Results reported in the main test derived from the adjusted models.
Results from the unadjusted models can be found in the online
Supplementary Material (Table S1). A significance test for the
predictor depressive symptoms was obtained by comparing the
full model with the same model while excluding the predictor
depressive symptoms, using a likelihood ratio test.
All analyses were carried out with the recommended stan-
dardized sampling weights for the SHS sample (44). Descriptive
analyses were performed using the IBM Statistical Package for
Social Sciences 21 (IBM Corp. Released 2012, IBM SPSS Statistics
for Windows, Version 21.0, Armonk, NY: IBM Corp.). Regression
analyses were performed using R, version 2.14.2 (63), including
the R package survey (64). All tests were two-tailed with a signif-
icance level of 0.05. We controlled for multiple testing using the
Holm–Bonferroni method (65).
RESULTS
Complete data were available for 14,348 subjects (51% of all
subjects reached by telephone). Table 1 presents the char-
acteristics of this subsample. Of the 14,348 subjects, 740
(weighted percentage= 5.2) were screened positive for depressive
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Table 1 | Sample characteristics (n=14,348).
Socio-demographics N % (%w)
Sex
Female 8,057 56.2 (51.1)
Male 6,291 43.8 (48.9)
Age in years
15–30 2,221 15.5 (24.0)
31–40 2,589 18.0 (17.5)
41–50 2,714 18.9 (19.5)
51–60 2,354 16.4 (15.1)
61–70 2,382 16.6 (12.5)
71+ 2,088 14.6 (11.3)
Educational level
Mandatory school 1,725 12.0 (11.7)
Secondary level 8,660 60.4 (61.7)
University 3,963 27.6 (26.7)
Occupation
Workpeople 3,428 23.9 (25.4)
Small business owners/
independent craftspeople
1,164 8.1 (7.6)
Office employee/other
non-manual professions
3,497 24.4 (22.9)
Middle/higher senior
management
5,628 39.2 (38.3)
Unknown 631 4.4 (5.8)
Median (25th–75th percentile)
Equivalized household
income in CHFa
3,700 (2,500–5,333)
n (%w)
Physical diseases With depressive
symptoms
n=740
Without depressive
symptoms
n=13,608
Any physical disease 270 (35.8) 4,127 (30.4)
Migraine 46 (6.1) 315 (2.3)
Asthma 28 (3.7) 354 (2.6)
Diabetes 23 (3.1) 398 (2.9)
Arthrosis, arthritis 82 (10.9) 1,104 (8.1)
Stomach ulcer, duodenal
ulcer
16 (2.1) 124 (0.9)
Osteoporosis 30 (4.0) 327 (2.4)
COPD, emphysema 23 (3.1) 249 (1.8)
High blood pressure 80 (10.6) 1,841 (13.5)
Myocardial infarction 8 (1.1) 173 (1.3)
Apoplexy 4 (0.5) 73 (0.5)
Renal disease, renal calculi 17 (2.3) 125 (0.9)
Cancer, blastoma 28 (3.7) 216 (1.6)
Allergies, hay fever 67 (8.9) 806 (5.9)
n, unweighted number of subjects; %w, weighted percentage; CHF, Swiss Franc,
COPD, chronic obstructive pulmonary disease.
aGradient between low and high income.
symptoms. The number of subjects with specific physical diseases,
stratified by the presence/absence of depressive symptoms, is
presented in Table 1.
Table 2 | Adjusted logistic regression modelsa of physical diseases
predicted by depressive symptoms (n=14,348).
Physical disease n of subjects
with
condition
OR (95% CI) puncontrolled/
pcontrolledb
Any physical disease 4,397 1.67 (1.33, 2.10) <0.001*/–
Migraine 361 2.07 (1.27, 3.39) 0.008*/0.087
Asthma 382 1.49 (0.91, 2.44) 0.137/0.694
Diabetes 421 2.05 (1.17, 3.61) 0.023*/0.182
Arthrosis, arthritis 1,186 1.79 (1.28, 2.50) 0.002*/0.021*
Stomach ulcer, duodenal ulcer 140 1.44 (0.71, 2.94) 0.340/1.000
Osteoporosis 357 1.86 (0.91, 3.81) 0.116/0.694
COPD, emphysema 272 2.33 (1.29, 4.21) 0.012*/0.123
High blood pressure 1,921 1.29 (0.92, 1.81) 0.159/0.694
Myocardial infarction 181 0.90 (0.33, 2.45) 0.828/1.000
Apoplexy 77 1.37 (0.33, 5.83) 0.680/1.000
Renal disease, renal calculi 142 2.63 (1.31, 5.29) 0.017*/0.149
Cancer, blastoma 244 2.45 (1.40, 4.30) 0.005*/0.064
Allergies, hay fever 873 1.59 (1.05, 2.41) 0.042*/0.297
OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary
disease.
*p<0.05.
aResults are adjusted for age, sex, education, occupation, and household income.
bControlled for multiple testing using Holm–Bonferroni method.
The results of the logistic regression models are presented in
Table 2. Depressive symptoms were associated with an increased
risk for migraine, diabetes, arthrosis and arthritis, COPD and
emphysema, renal disease and renal calculi, cancer and blastoma,
allergies like hay fever, and the risk for any physical disease.
However, after Holm–Bonferroni correction, only the associa-
tion of depressive symptoms with arthrosis and arthritis remained
(OR= 1.79, 95% CI= 1.28-2.50).
DISCUSSION
The aim of the present analyses was to estimate the association
between depressive symptoms and physical diseases in a rep-
resentative population sample in Switzerland. The presence of
depressive symptoms was associated with an increased risk for
any physical disease and after correcting for multiple testing with
an increased risk for arthrosis and arthritis.
To the best of our knowledge, this is the first study to deter-
mine the pattern of comorbidity of depressive symptoms and
physical diseases in Switzerland. Our results are in line with
previous studies reporting associations between depression and
physical diseases in general (66–70) and associations between
depression and arthrosis and arthritis (6, 11, 71, 72) in partic-
ular. Moreover, our findings are in line with findings on the
high prevalence of depression in patients with different physical
diseases (26), as well as in patients with musculoskeletal disor-
ders, such as osteoarthritis and rheumatoid arthritis (11, 12).
In addition, a recent meta-analysis confirmed the high preva-
lence of depression in patients with rheumatoid arthritis (13).
However, our findings are not in line with previous studies
reporting comorbid depressive symptoms in patients with car-
diovascular disease (18, 73), diabetes (9, 10), or COPD (16, 17).
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However, this might be due to a relatively lower statistical power
and related less precise estimation of comorbidity for those
physical diseases under study with lower prevalence (including,
stomach and duodenal ulcer, COPD and emphysema, myocar-
dial infarction, apoplexy, renal disease and calculi, cancer, and
blastoma).
Due to the cross-sectional nature of this study, we are not able to
draw conclusions about the causality of the estimated associations.
We consider three different models to explain the estimated asso-
ciations: (A) depressive symptoms may lead to physical diseases,
more specifically to arthrosis and arthritis; (B) physical diseases,
among other arthrosis and arthritis, may lead to depressive symp-
toms; (C) there may be common factors leading to both depressive
symptoms and physical diseases, especially arthrosis and arthritis.
With regard to (A), it has been shown that depressive symptoms
cause disability (1) and are related to a loss of interest in everyday
activities (74). Moreover, depressive symptoms have been associ-
ated with unfavorable health behavior, such as smoking (75, 76).
Therefore, one may speculate that depressive symptoms may, via
unfavorable health behavior, pave the way for chronic physical
disease. More specifically, depression is related to reduced physical
activity (77) and that has been associated with musculoskeletal
disorders, such as osteoarthritis (12).
With regard to (B), one may speculate that having a chronic
physical disease decreases quality of life (78, 79), which might
affect the mental health status of a person with a physical dis-
ease (23, 80, 81) resulting in reduced subjective well-being and
ability to cope with everyday life in individuals with poor mental
health (82). The perception of being unable to cope with every-
day requirements has been associated with depression (83, 84) and
this might lead to a loss of interest in daily activities, resulting in
decreased positive reinforcement to participate in everyday life,
which has been associated with depression (85, 86). More specif-
ically, arthrosis and arthritis have been associated with reduced
physical activity (87) and it has been shown that physical activ-
ity has a beneficial effect on depressive symptoms (88–90). Thus,
arthrosis and arthritis might therefore favor the development of
depressive symptoms.
With regard to (C), we can only speculate about potential
further factors. Interestingly, different immune parameters, such
as cytokines, have been associated with both depressive symp-
toms (91) and physical diseases (68, 92). Whether these para-
meters represent mediators of the observed associations or com-
mon risk factors for depression and physical diseases is largely
unknown. Thus, further research is needed to scrutinize the
mechanisms underlying the association between depression and
physical diseases.
Our analysis has several strengths: first, we included a rep-
resentative population sample totaling 14,348 subjects. Second,
the presence of physical diseases was verified by receiving treat-
ment from a medical doctor. Third, we controlled for potential
confounders that have been previously linked to depression (56–
58) and physical diseases (59). Finally, we corrected for multiple
testing, as recommended (93–95).
This study also has limitations and our findings need replica-
tion in an independent dataset. First, the non-response rate within
the SHS might have caused a selection bias (96). Therefore future
studies aiming to a higher response rate are needed in Switzerland.
Second, we were not able to determine the severity of depressive
symptoms and any of the physical diseases, as this information was
not available from the SHS data. This might have led to underesti-
mation of conditions present in the general population. Therefore,
studies precisely aiming to investigate the prevalence and sever-
ity of depressive symptoms and depressive disorders, as well as
physical diseases, in the general population are urgently needed in
Switzerland. Future studies should allow for the detection of subtle
variations of depressive symptoms in the general population, and
estimate how these variations relate to comorbidity with physical
diseases. Third, physical diseases were assessed with a self-report
checklist. However, comparable checklists highly accorded with
medical records (53, 54) and showed better accuracy than con-
sultation rates in national studies (55). Furthermore, all data on
physical diseases and corresponding disease categories were prede-
fined in the SHS. Thus, we were not able to analyze the conditions
arthrosis and arthritis as separate diagnoses, as this information
was not available from the SHS data. However, both conditions are
diseases of the musculoskeletal system and connective tissue and
involve similar symptoms, such as pain and inflammation (97).
With regard to generalizability of the findings, caution is war-
ranted. It is questionable whether our findings on the association
between depressive symptoms and physical diseases in Switzer-
land are applicable to other high-income countries because of
Switzerland’s high performing health care system (34). However,
our results on the association between depressive symptoms and
arthrosis and arthritis in Switzerland do not substantially dif-
fer from representative community-based results in Canada (7),
which is also a high-income country (32).
Due to the cross-sectional nature of our study, we abstained
from expressing a clear preference for one of the possible expla-
nations given for the associations between depressive symptoms
and any physical diseases, respectively, arthrosis and arthritis. In
this study, depressive symptoms were associated with any physical
disease and depressive symptoms were related to an increased risk
for arthrosis and arthritis. Our findings may contribute to a better
understanding of the comorbidity of depressive symptoms and
physical diseases, as well as provide the basis for a better under-
standing of the changes of mental–physical comorbidity over time
in Switzerland. We found that depressive symptoms were related to
arthrosis and arthritis, which might have implications for clinical
practice. They suggest considering to encourage the screening of
subjects with arthrosis and arthritis for depressive symptoms and
vice versa. Early recognition of the co-occurrence of depressive
symptoms with arthrosis or arthritis might allow for an improved
coordination of interdisciplinary treatment (specialized therapies
depending on the outcome of the screening) and this may posi-
tively influence the course of both conditions. Treatment costs of
physical diseases are higher for subjects with co-occurring depres-
sive symptoms than for subjects without depressive symptoms
suffering from the same disease (39–41). Thus, knowledge about
the comorbidity of depression and physical diseases may allow a
more comprehensive estimate of the overall costs related to depres-
sion. Therefore, our results might have implications for more
precise future estimates of costs related to depression, including
secondary costs, related to increased expenditures for co-occurring
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physical conditions in Switzerland. Additionally, by accounting for
co-occurrence of comorbid conditions, double counting can be
avoided (1), which might contribute to more precise future esti-
mates for costs of co-occurring depressive symptoms and physical
diseases.
Future studies should focus on the mechanisms underlying
the association between depressive symptoms and the increased
risk for physical disease in general and arthrosis and arthritis in
particular.
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ABSTRACT 
 
Background: With the growth and online expansion of the gambling industry, games of 
chance have become more accessible. Pathological gambling has been associated with 
physical diseases. Whether gambling behavior itself is associated with physical diseases is 
still to be determined.  
Objective: To estimate if gambling is associated with a wide range of non-communicable 
physical diseases in a population-based survey.  
Methods: Population-based study, using data from the Swiss Health Survey collected during 
the year 2007 (n=18,760, age>15 years) in Switzerland. Complete data was available for 
11,385 subjects (61% of interviewed subjects). We conducted separate logistic regression 
models with each out of five non-communicable physical diseases or any physical disease in 
the past 12 months as outcomes. We used gambling versus not gambling in the past 12 
months as predictor, controlling for sex, age, education, occupation, and household income.  
Results: Subjects who reported to have gambled in the past 12 months had an increased risk 
of diabetes (Odds Ratio [OR]=1.34, 95%Confidence Interval [CI]=1.02−1.75), arthrosis and 
arthritis (OR=1.29, 95%CI=1.07−1.56), high blood pressure (OR=1.20, 95%CI=1.03−1.40), 
allergies like hay fever (OR=1.36, 95%CI=1.10−1.68), and any physical disease (OR=1.25, 
95%CI=1.10−1.41).  
Conclusions: Our findings contribute to a better understanding of the co-occurrence of 
gambling and physical diseases and might have implications for the prevention of physical 
diseases associated with gambling. Understanding the association between gambling and 
physical conditions might assist in the reduction of the costs to the health care system. 
 
Keywords: gambling, comorbidity, co-occurrence, correlates, physical diseases  
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Introduction 
Gambling, in terms of participating in games of chance with an opportunity to profit, is a 
widespread behavior (Bundeszentrale für gesundheitliche Aufklärung, 2014, Hodgins et al., 
2011, Wardle et al., 2011, Welte et al., 2002), with up to 82% of the general adult population 
in the US engaging in gambling within 12 months (Welte et al., 2002). In Germany, 39% to 
55% of the general adult population reported having participated in some sort of gambling in 
the past 12 months (Bundeszentrale für gesundheitliche Aufklärung, 2014). In 2011 the 
overall European gambling market showed a projected annual growth rate of approximately 
3%, with online gambling showing the highest annual growth rate of around 15% (European 
Commission, 2012). Persistent problematic gambling behavior leading to clinically significant 
impairment, defined as Gambling Disorder in the Diagnostic and Statistical Manual of Mental 
Disorders 5
th 
edition (DSM-5) (American Psychiatric Association, 2013), formerly referred to 
as “Pathological Gambling” in the Diagnostic and Statistical Manual of Mental Disorders 4th 
edition (DSM-IV) (American Psychiatric Association, 1994), has been associated with several 
mental disorders, such as affective and substance use disorders (Dowling et al., 2015, El-
Guebaly et al., 2006, Lorains et al., 2011, Petry et al., 2005, Yip et al., 2011). Moreover, 
pathological gambling has been associated with lower social functioning and psychosocial 
wellbeing (Bergh and Kuhlhorn, 1994), poorer general physical health (Erickson et al., 2005, 
Morasco et al., 2006b), and lower physical activity and obesity (Black, Shaw, McCormick, & 
Allen, 2013). 
 
Notably, physical inactivity, obesity, tobacco use and alcohol abuse are among the leading 
risk factors for mortality, as they raise the risk for chronic non-communicable physical 
diseases (World Health Organization, 2009). According to the World Health Organization, 
more than 36 million people die of non-communicable physical diseases worldwide, with the 
main causes of death being cardiovascular diseases, cancer, diabetes and chronic lung 
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diseases (World Health Organization, 2011). However, and to the best of our knowledge, 
there are only three publications based on large (> 10,000 participants) nationally 
representative samples estimating the association between pathological gambling and selected 
physical diseases (Black et al., 2013).  
 
Notably, all three publications were based on data from the National Epidemiologic Survey 
on Alcohol and Related Conditions, including a representative sample of 43,093 
noninstitutionalized adults in the U.S. Pathological gamblers (subjects who had gambled five 
or more times in a single year and fulfilled at least five out of ten DSM-IV criteria for 
pathological gambling) more frequently reported to be diagnosed (self-reported medical 
diagnoses) with tachycardia, angina, cirrhosis, and other liver diseases in the past year than 
individuals who were identified as at low-risk for gambling (subjects who had never gambled 
and those who may have gambled in their lifetime, but not more than five times in a single 
year) (Morasco et al., 2006a). Moreover, participants identified as problem gamblers 
(gambled five or more times in a single year and met three or four DSM-IV pathological 
gambling symptoms) and at-risk gamblers (gambled five or more times in a single year and 
met zero to two DSM-IV symptoms) more likely reported to be diagnosed with hypertension 
in the past year than low-risk individuals, whereas problem gamblers more frequently 
reported to be diagnosed with angina and cirrhosis in the past year than low-risk individuals 
(Morasco et al., 2006a). Older subjects (60 years and older) with a lifetime history of 
disordered gambling (category includes problem and pathological gamblers, who gambled 
five or more times in a single year and met at least three, respectively five, DSM-IV 
symptoms for pathological gambling in the past year and/or at some previous point in 
lifetime) more likely had a past-year diagnosis of angina and arthritis than older non-gamblers 
(subjects who had never gambled five or more times in a single year in their lifetime) 
(Pietrzak et al., 2007). Problem gamblers between 40 to 64 years (gambled five or more times 
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in a single year and met at least three DSM-IV symptoms) more frequently reported to be 
diagnosed with obesity, heart disease, cirrhosis and other liver diseases, stomach diseases, 
arthritis, and any chronic medical condition in the past year than recreational gamblers 
(gambled more than five times in a single year in their lifetime and met zero to two DSM-IV 
symptoms) and non-gamblers (never gambled more than five times in a single year in their 
lifetime) (Desai et al., 2007). Another study, comparing pathological gamblers (lifetime South 
Oaks Gambling Score and DSM-IV Screen for Gambling Problems over five, and met DSM-
IV criteria for pathological gambling) (n = 95) to matched subjects not engaging in gambling 
(lifetime South Oaks Gambling Score below two and DSM-IV Screen for Gambling Problems 
score of zero) (n = 91), reported higher prevalence of any chronic physical health condition 
(self-reported), obesity, heartburn/stomach condition, headache, and sleep disorders (Black et 
al., 2013) in pathological gamblers as compared to non-gamblers. A recent study assessing 
self-reported gambling addiction (comparable with pathological gambling) in participants 
from the general population in Japan (n = 5,003) did not find any associations between 
lifetime gambling addiction and a wide range of current self-reported chronic physical 
diseases, except for the association between gambling addiction and hay fever (Shiue, 2015). 
Taken together, these studies provided evidence for associations between pathological 
gambling and a variety of physical diseases. More specifically, pathological gambling (past 
12 months and lifetime) was linked to an increased risk for certain physical diseases in the 
past 12 months. However, these findings remain heterogeneous due to the different criteria 
and thresholds for pathological gambling, as well as assessment instruments used to assess 
gambling behavior. It is not yet known whether gambling behavior per se, as an important 
dimension of Gambling Disorder, is associated with physical diseases.  
To the best of our knowledge, this is the first study assessing the association between 
gambling behavior and non-communicable physical diseases in a large-scale, nation-wide, 
representative population-based survey. 
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The purpose of this study was to estimate whether gambling is associated with a wide range 
of physical diseases. More specifically, we wanted to estimate whether subjects who had 
gambled in the past 12 months compared with subjects who had not gambled in the past 12 
months had an increased risk for any or a specific physical disease in the past 12 months.  
 
Methods 
Design and sample 
This study is based on data from the Swiss Health Survey (SHS), carried out by the M.I.S.-
Trend S.A Institute in Lausanne and Gümligen in 2007 and conducted by the Swiss Federal 
Statistical Office (Bundesamt für Statistik, 2008). The data collection and storage for the 
Swiss Health Survey does not require formal approval by an ethical committee, as this data 
collection, preparation and storage are specifically permitted under Swiss law and participants 
could decline to participate or withdraw at any time (SR 431.012.1; SR 431.112.1). The 
authors of this manuscript were not involved in data collection. Anonymized data for further 
analyses was obtained upon signing a data confidentiality and privacy contract from the Swiss 
Federal Statistical Office.  
The SHS is a cross-sectional, periodic survey, including a computer assisted telephone 
interview and an additional written questionnaire. Subjects aged 15 and older, living in 
private Swiss households with a telephone connection in 2007, were part of the multistage 
stratified random sample. Out of 30,179 randomly selected private households, 18,760 
completed the telephone interview, corresponding to a response rate of 66% (Bundesamt für 
Statistik, 2008) (Figure 1). The SHS methodology and sampling have been described 
elsewhere (Graf, 2010).  
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FIGURE 1. Flowchart of study participants 
 
 
Assessment of Gambling 
Gambling was assessed with self-report questions in the SHS survey. Subjects first answered 
the question Have you ever played games of chance in your lifetime? with the reply categories 
Yes, at least once in lifetime and No, I have never played. Subjects who replied Yes, at least 
once in lifetime or did not reply (did not give an answer) to this question were further asked 
Have you played games of chance in the past 12 months? with the reply categories Yes, No 
and a category containing subjects who did not give an answer. Out of the replies to these two 
questions we build the following two gambling categories: 1) Gambled in the past 12 months 
(replied Yes, at least once in lifetime to the first question and Yes to the second question, or 
did not reply to the first question and replied Yes to the second question) and 2) Not gambled 
in the past 12 months (replied Yes, at least once in lifetime to the first question and No to the 
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second question; or replied No, I have never played to the first question; or did not reply to 
the first question and replied No to the second question). All participants, who replied Yes, at 
least once in lifetime to the first question and did not reply to the second question; or did not 
reply to the first and the second question, were treated as ambiguous or missing information 
and were therefore not included in the statistical analyses. Thus, the gambling variable 
consisted of the two categories Gambled in the past 12 months and Not gambled in the past 
12 months. 
 
Assessment of physical diseases 
In the SHS, common non-communicable physical diseases were assessed with a self-report 
checklist, based on the European Health Interview Survey (Eurostat Working Group on 
Public Health Statistics, 2006). Participants were asked whether they received recent (more 
than 12 months ago) or current (during the past 12 months) treatment by a medical doctor for 
each physical disease out of a list of 13 conditions. We used the presence/absence of each 
physical disease in the past 12 months or any out of the 13 physical diseases combined as 
outcome. The diseases included migraine, asthma, diabetes, arthrosis and arthritis, stomach 
ulcer and duodenal ulcer, osteoporosis, chronic obstructive pulmonary disease (COPD) and 
emphysema, high blood pressure, myocardial infarction, apoplexy, renal disease and renal 
calculi, cancer and blastoma, and allergies like hay fever. Comparable checklists have shown 
high agreement with medical records (Baker et al., 2004, National Center for Health 
Statistics, 1994) and better accuracy than consultation rates in national studies (Knight et al., 
2001).  
 
Assessment of socio-demographic measures  
We considered sex, age, education, occupation, and equivalised household income as 
covariates, as these characteristics have previously been linked to gambling (Johansson et al., 
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2009) and physical diseases (Dalstra et al., 2005). We grouped age into six categories: 15–30 
years, 31–40 years, 41–50 years, 51–60 years, 61–70 years and 71 years and above. In the 
SHS, the educational level comprised three categories: mandatory school, secondary school 
and university (Bundesamt für Statistik, 2007). Occupation was categorized into the five 
categories middle/higher senior management, office employees/other non-manual professions, 
small business owners/independent craftspeople, workpeople, and unknown based on the 
Erikson-Goldthrope-Portocarero classification of occupation (Bundesamt für Statistik, 2007, 
Erikson et al., 1979). In the SHS, the equivalised household income, a continuous index 
representing a gradient between low and high income, was calculated by dividing the monthly 
household income by the weighted number of persons in the household, where a weight of 1.0 
was set for the first person over 15 years, 0.5 for each additional person and 0.3 for each child 
under 15 years (Bundesamt für Statistik, 2007, Statistical Commission and Economic 
Commission for Europe, 1994).  
 
Statistical analyses 
Our goal was to examine the associations between gambling and the presence/absence of 
physical diseases in the past 12 months. Some of the disease categories comprised a small 
number of cases with the respective condition. Although it has been shown that a minimum of 
5 events per predictor variable is sufficient for logistic regression models (Vittinghoff and 
McCulloch, 2007), we wanted to be conservative and only included disease categories with a 
minimum of 10 events per predictor in the analyses (Peduzzi, Concato, Kemper, Holford, & 
Feinstein, 1996). Thus, the following eight disease categories were excluded from further 
analyses: migraine, stomach and duodenal ulcer, osteoporosis, COPD and emphysema, 
myocardial infarction, apoplexy, renal diseases and renal calculi, as well as cancer and 
blastoma. The five remaining physical disease categories asthma, diabetes, arthrosis and 
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arthritis, high blood pressure, and allergies like hay fever, as well as the presence of any of all 
13 diseases (any physical disease) were used in the analyses.  
We conducted separate logistic regression models with each of the five physical diseases 
(yes/no) or all 13 combined diseases (any physical disease; yes/no) as outcomes. We used 
gambling as predictor with the two categories 1) Gambled in the past 12 months and 2) Not 
gambled in the past 12 months. All models were adjusted for the following covariates: sex, 
age, education, occupation, and equivalised household income outlined in Table 1. As the 
equivalised household income comprised missing values, we created an additional predictor 
indicating whether a value for equivalised household income was present or not. If a value for 
the equivalised income was present then the income category was added to the analyses. For 
the sake of transparency, we provided additional crude results based on logistic models 
unadjusted for covariates, in the online supplement (Table 3).  
 
All analyses were carried out with the recommended standardized sampling weights for the 
SHS sample (Graf, 2010). Analyses were performed using R, version 2.14.2 (R Development 
Core Team, 2012), including the R package survey (Lumley, 2012). All tests were two-tailed 
with a significance level of 0.05.  
 
Results  
Complete data was available for 11,385 subjects. Table 1 presents the characteristics of this 
sample stratified according to gambling behavior (Gambled in the past 12 months or Not 
gambled in the past 12 months). 
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TABLE 1. Sample Characteristics (n = 11,385)
 
 
 
Socio-demographics 
Gambled in the past 
12 months 
(n = 5,624) 
Not gambled in the past 
12 months 
(n = 5,761) 
Total sample 
(n = 11,385) 
Sex (n, %
 w
)
 
   
Female
 
2,755 (43.1) 3,625 (58.9) 6,380 (51.0) 
Male
 
2,869 (56.9) 2,136 (41.1) 5,005 (49.0) 
Age in years (n, %
 w
)*     
15-30
 
967 (26.7) 918 (24.8) 1,885 (25.7) 
31-40
 
1,180 (19.9) 904 (15.1) 2,084 (17.5) 
41-50
 
1,167 (20.5) 990 (18.0) 2,157 (19.3) 
51-60 1,023 (15.9) 888 (14.7) 1,911 (15.3) 
61-70 822 (10.8) 1,012 (13.2) 1,834 (12.0) 
71+ 465 (6.1) 1,049 (14.1) 1,514 (10.1) 
Educational Level (n, %
 w
)     
Mandatory School 580 (10.2) 726 (12.5) 1,306 (11.4) 
Secondary Level 3,604 (65.0) 3,389 (60.2) 6,993 (62.6) 
University 1,440 (24.8) 1,646 (27.3) 3,086 (26.0) 
Occupation (n, %
 w
)*     
Workpeople 1,417 (27.0) 1,297 (23.9) 2,714 (25.4) 
Small business owners
a
  431 (7.2) 493 (7.9) 924 (7.5) 
Office employee
 
(and other non-manual) 1,473 (25.1) 1,355 (21.5) 2,828 (23.3) 
Senior management
 
(middle and higher) 2,150 (36.3) 2,275 (39.1) 4,425 (37.7) 
Unknown  153 (4.3) 341 (7.6) 494 (6.0) 
Equivalised household income in CHF
 b
 
(Median, 25th−75th percentile) 
3,733 (2,581−5,333) 3,600 (2,400−5,100) 3,696 (2,500−5,250) 
Physical diseases     
Any physical disease
c
 (n, %
w
) 1,835 (29.3) 2,008 (30.9) 3,843 (30.1) 
Migraine
c
 (n, %
w
) 146 (2.8) 170 (3.2) 316 (3.0) 
Asthma
c 
(n, %
w
) 175 (3.0) 173 (3.1) 348 (3.0) 
Diabetes
c 
(n, %
w
) 181 (2.6) 183 (2.6) 364 (2.6) 
Arthrosis, Arthritis
c 
(n, %
w
) 466 (6.8) 560 (7.6) 1,026 (7.2) 
Stomach Ulcer, Duodenal Ulcer
c 
(n, %
w
) 64 (1.0) 63 (1.0) 127 (1.0) 
Osteoporosis
c
 (n, %
w
) 99 (1.3) 221 (2.9) 320 (2.1) 
COPD, Emphysema
c
 (n, %
w
) 126 (2.1) 124 (1.9) 250 (2.0) 
High Blood Pressure
c 
(n, %
w
) 765 (11.5) 917 (13.3) 1,682 (12.4) 
Myocardial Infarction
c 
(n, %
w
) 74 (1.0) 86 (1.5) 160 (1.2) 
Apoplexy
c 
(n, %
w
) 33 (0.5) 38 (0.4) 71 (0.4) 
Renal Disease, Renal Calculi
c 
(n, %
w
) 77 (1.2) 52 (0.8) 129 (1.0) 
Cancer, Blastoma
c 
(n, %
w
) 105 (1.8) 109 (1.8) 214 (1.8) 
Allergies, Hay Fever
c
 (n, %
w
) 434 (8.4) 347 (6.7) 781 (7.5) 
n = unweighted number of subjects; %
w
 = weighted percentage; CHF = Swiss Franc, COPD = chronic obstructive pulmonary disease. 
* % may not sum up to 100% due to rounding.  
a 
Including independent craftspeople. 
b 
Gradient between low and high income. Missing information on equivalised household income: number of missings = 535. 
c 
Analyses are based on completer samples due to missing information on physical diseases (migraine: n = 10,855; asthma: n = 10,881; 
diabetes: n = 10,792; arthrosis, arthritis: n = 10,954; stomach ulcer, duodenal ulcer: n = 10,852; osteoporosis: n = 10,884; COPD, 
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The results of the adjusted logistic regression models are presented in Table 2. Subjects who 
gambled in the past 12 months had an increased risk of diabetes (OR = 1.34, 95% CI = 
1.02−1.75), arthrosis and arthritis (OR = 1.29, 95% CI = 1.07−1.56), high blood pressure (OR 
= 1.20, 95% CI = 1.03−1.40), allergies like hay fever (OR = 1.36, 95% CI = 1.10−1.68), and 
any physical disease (OR = 1.25, 95% CI = 1.10−1.41) as compared to subjects who did not 
gamble in the past 12 months. 
 
TABLE 2. Association between gambling and physical diseases. Results based on adjusted
a
 logistic regression 
models (n = 11,385).
 
  Gambled vs. not gambled 
 in the past 12 months 
 
 
 
Physical Disease 
Total n 
of subjects with physical 
disease 
 
 
 
OR (95% CI) 
 
 
 
p 
Any Physical Disease
b 
3,837 1.25 (1.10, 1.41) <0.001* 
Asthma
b 
348 1.12 (0.83, 1.52) 0.447 
Diabetes
b 
363 1.34 (1.02, 1.75) 0.034* 
Arthrosis, Arthritis
b 
1,025 1.29 (1.07, 1.56) 0.008* 
High Blood Pressure
b 
1,677 1.20 (1.03, 1.40) 0.023* 
Allergies, Hay Fever
b
 781 1.36 (1.10, 1.68) 0.004* 
n = unweighted number of subjects, OR = Odds Ratio, CI = Confidence Interval 
* p < 0.05 
a 
Results are adjusted for age, sex, education, occupation, and household income. 
b 
Due to missing information on physical diseases, analyses are based on completer samples (asthma: n = 10,881; diabetes: n = 10,792; 
arthrosis, arthritis: n = 10,954; high blood pressure: n = 11,087; allergies, hay fever: n = 10,886; any physical disease: n = 10,451). 
 
Discussion  
The aim of the current study was to estimate the association between gambling and physical 
diseases in a representative population sample. Subjects who gambled in the past 12 months 
compared to subjects who did not gamble in the past 12 months showed an increased risk for 
diabetes, arthrosis and arthritis, high blood pressure, allergies like hay fever, and any physical 
disease in the past 12 months.  
emphysema: n = 10,866; high blood pressure: n = 11,087; myocardial infarction: n = 10,874; apoplexy: n = 10,851; renal disease, 
renal calculi: n = 10,870; cancer, blastoma: n = 10,885; allergies, hay fever: n = 10,886; any physical disease: n = 10,451). 
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Our finding that gambling in the past 12 months was associated with an increased risk for any 
physical disease is in line with previous research on the association between pathological 
gambling and physical diseases (Black et al., 2013, Morasco et al., 2006a, Pasternak and 
Fleming, 1999). Our finding that gambling in the past 12 months was associated with an 
increased risk for diabetes is not in line with one other study reporting no associations 
between pathological gambling and diabetes (Black et al., 2013). However, the sample of the 
study by Black and colleagues (2013) comprised only a small number of individuals reporting 
diabetes, thus, the confidence interval of the estimates may have been too large to provide 
precise results. Our finding that gambling in the past 12 months was associated with an 
increased risk for arthrosis and arthritis is in line with two publications reporting association 
between pathological gambling and arthrosis and arthritis (Desai et al., 2007, Pietrzak et al., 
2007). Our finding that gambling in the past 12 months was associated with an increased risk 
for high blood pressure is in line with one study reporting associations between problematic 
gambling and high blood pressure (Morasco et al., 2006a), whereas another study did not find 
any associations between pathological gambling and high blood pressure (Black et al., 2013). 
A possible explanation for these discrepant findings might be the large difference in sample 
size between the study by Morasco et al. (2006a) and the study by Black et al. (2013). 
Another possible explanation is that we assessed gambling behavior as an activity without 
explicitly focusing on pathological gambling. However, gambling is an important dimension 
of Gambling Disorder (American Psychiatric Association, 2013) and research on gambling 
behavior itself, including recreational as well as pathological gambling, might therefore reveal 
the associations between gambling and physical diseases more clearly. Our finding that 
gambling in the past 12 months was associated with allergies like hay fever is in line with one 
study reporting associations between gambling addiction and hay fever (Shiue, 2015). Due to 
the cross-sectional nature of this study, we were not able to draw conclusions about the 
causality of the estimated associations. However, we considered three different models to 
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explain the estimated associations. First, gambling has been associated with unfavorable 
health behavior, such as alcohol abuse and nicotine dependence (Dowling et al., 2015), lower 
physical activity, and obesity (Black et al., 2013). As it has been shown that alcohol abuse, 
tobacco addiction, lower physical activity, and obesity are risk factors for a wide range of 
physical diseases, such as diabetes, arthrosis and arthritis, and high blood pressure (World 
Health Organization, 2011), one may speculate that gambling, via unfavorable health 
behavior, might pave the way for physical diseases. With regard to allergies like hay fever, 
one may speculate that in vulnerable individuals (family history of allergies) (Kaiser, 2004) 
unfavourable behavior associated with gambling, such as smoking cigarettes (Dowling et al., 
2015), might pave the way for the allergic condition. Second, one may speculate that the 
disability caused by physical diseases (World Health Organization, 2011) limits a subjects 
ability to perform daily routines and tasks, which might result in long periods of inactivity in 
which the subject may resort to gambling. Third, there may be common factors leading to 
both, gambling and physical diseases, although we can only speculate about potential 
underlying factors. For example, physical inactivity and obesity have been associated with 
both gambling (Black et al., 2013) and physical diseases (World Health Organization, 2009). 
Notably, whether these factors represent mediators of the observed associations or common 
risk factors for gambling and physical diseases is largely unknown. Thus, further research is 
needed to scrutinize the mechanisms underlying the association between gambling and 
physical diseases. 
 
Our analyses have several strengths: First, we included a representative population sample 
totaling 11,385 subjects. Second the presence of physical diseases was verified by receiving 
treatment from a medical doctor. Third, we controlled for potential confounders that have 
been previously linked to gambling and physical diseases.  
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This study also has limitations and our findings need replication in an independent dataset. 
First, the non-response rate within the SHS might have caused a selection bias (Volken, 
2013). Therefore future studies aiming at a higher response rate are needed. Second, we were 
not able to determine the severity of any of the physical diseases, as this information was not 
available from the SHS data. Third, physical diseases were assessed with a self-report 
checklist. However, comparable checklists highly accorded with medical records (Baker et 
al., 2004, National Center for Health Statistics, 1994) and showed better accuracy than 
consultation rates in national studies (Knight et al., 2001).  
We refrained from applying the Bonferroni method to adjust for multiple testing, as the 
approach is critically discussed as too conservative, leading to lower power and increasing 
publication bias (Nakagawa, 2004, Perneger, 1998).  
As we assessed gambling behavior itself and not pathological gambling, caution is warranted 
with regard to generalizability of the findings to pathological gamblers. However, we believe 
that our findings can be generalized to other community-based samples, as our results on the 
association between gambling and physical diseases do not substantially differ from other 
studies (Black et al., 2013, Morasco et al., 2006a, Pasternak and Fleming, 1999).  
If the causality between gambling and physical diseases is confirmed in future studies, our 
results might point to the importance of the early assessment of gambling behavior in general, 
not only pathological gambling. Our findings might have implications for the prevention of 
physical diseases in gamblers through the assessment of gambling behavior and associated 
risk-factors. The treatment of non-communicable physical diseases is highly cost intensive 
(World Health Organization, 2011), thus an argument can be made that through early 
recognition of pathological gambling and associated risk-factors as well as physical 
conditions, the costs to the health care system could be reduced. Moreover, pathological 
gambling is strongly associated with financial problems (Holdsworth et al., 2013, Ladouceur 
et al., 1994, Mathews and Volberg, 2013) and might therefore increase societal costs 
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(inability to pay for health insurance, debts). Physical health problems arising from 
pathological gambling further add to that burden. 
  
In this study gambling in the past 12 months was associated with an increased risk for 
diabetes, arthrosis and arthritis, high blood pressure, allergies like hay fever, and any physical 
disease. Our findings may contribute to a better understanding of correlates of gambling in the 
general population. Moreover, if confirmed in independent samples, our findings may point to 
the potential effect of gambling on the development of physical diseases. Thus, our findings 
may have implications for the prevention of physical diseases. Future studies should focus on 
the mechanisms underlying the association of gambling and physical diseases in general and 
diabetes, arthrosis and arthritis, high blood pressure, and allergies like hay fever in particular. 
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Other Supplementary Material 
TABLE 3. Association between gambling and physical diseases. Results based on unadjusted logistic regression 
models (n = 11,385).
 
  Gambled vs. not gambled 
 in the past 12 months 
 
 
 
 
Physical Disease 
 
Total n 
of subjects with physical 
disease 
 
 
 
 
OR (95% CI) 
 
 
 
 
p 
Any Physical Disease
a 
3,837 0.93 (0.83, 1.03) 0.157 
Asthma
a 
348 0.98 (0.73, 1.31) 0.863 
Diabetes
a 
363 1.02 (0.78, 1.34) 0.886 
Arthrosis, Arthritis
a 
1,025 0.88 (0.74, 1.04) 0.145 
High Blood Pressure
a 
1,677 0.85 (0.74, 0.97) 0.017* 
Allergies, Hay Fever
a
  781 1.27 (1.04, 1.56) 0.021* 
n = unweighted number of subjects, OR = Odds Ratio, CI = Confidence Interval 
* p < 0.05 
a 
Due to missing information on physical diseases, analyses are based on completer samples (asthma: n = 10,881; diabetes: n = 10,792; 
arthrosis, arthritis: n = 10,954; high blood pressure: n = 11,087; allergies, hay fever: n = 10,886; any physical disease: n = 10,451). 
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Abstract 
 
Background: Somatoform Disorders or Somatic Symptom and Related Disorders are a major 
public health problem. The pathophysiology underlying these disorders is not yet understood. 
Purpose: The aim of this study was to explore if sensory responsiveness could contribute to a 
better understanding of pathophysiological mechanisms underlying two key symptoms of 
Somatoform Disorders, namely somatic symptoms and illness anxiety.  
Methods: We measured vibrotactile perception thresholds with the HVLab Perception Meter 
and examined their association with somatic symptoms, illness anxiety and trait anxiety. A 
sample of 205 volunteers participated in the study.  
Results: Sensory responsiveness was neither associated with somatic symptoms (β=−0.01; 95 
% confidence interval (CI), −0.37, 0.39) nor trait anxiety (β=−0.07; 95 % CI, −0.30, 0.07). 
However, lower vibrotactile perception thresholds were associated with increased scores of 
the overall illness anxiety scale (β=−0.65; 95 % CI, −1.21, −0.14) and its constituent subscale 
disease conviction (β=−2.07; 95%CI, −3.94, −0.43). 
Conclusions: Our results suggest that increased sensory responsiveness is associated with 
illness anxiety and hence should be examined further as potential target within the 
etiopathology of somatoform disorders.  
 
Keywords illness anxiety, medically unexplained somatic symptoms, sensory responsiveness, 
vibrotactile perception threshold 
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Abbreviations 
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders IV 
DSM-5 = Diagnostic and Statistical Manual of Mental Disorders 5 
VPT = Vibrotactile perception threshold 
EKBB = Ethics Committee Basel 
SOMS = Screening for Somatoform Symptoms 
WI = Whiteley-Index 
STAI = State-Trait Anxiety Inventory 
SES = Socio-Economic Status 
dB = Decibel 
Hz = Hertz 
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Introduction 
Ten to fifteen percent of primary care patients report persistent bodily complaints for which 
no clear organic reason can be found (medically unexplained symptoms) [1–3], while up to 20 
% of patients in primary care studies fulfill the diagnostic criteria for Somatoform Disorders 
according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSMIV) 
[4].  
 
Within the diagnostic category of Somatoform Disorders, all disorders share the following 
common aspects: the presence of bodily complaints that are not fully explainable by a medical 
condition, other mental disorder or by the effect of any substance, the affected subject does 
not meet the criteria for malingering or factitious disorder, and the complaints cause 
substantial impairment in at least one area of life [5]. The functional impairment associated 
with these conditions is comparable with that seen in Anxiety and Depressive Disorders [6, 
7]. This DSM-IV category of mental disorders includes Somatization Disorder, 
Undifferentiated Somatoform Disorder, Conversion Disorder, Pain Disorder, 
Hypochondriasis, Body Dysmorphic Disorder and Somatoform Disorder Not Otherwise 
Specified [5]. Clinically relevant somatization, in terms of psychological needs being 
expressed as physical symptoms are major public health problem affecting 20.4 million 
persons annually in Europe [8]. Moreover, it leads to excessive health care use, costing the 
US health care system an estimated $100 billion annually [9].  
 
In recent years, different models on the etiology of Somatoform Disorders have been 
proposed [10–13]. Among them is an innovative conceptual model, restructuring and 
extending existing theories on dissociation (attentional dysfunction due to traumatic memories 
triggers somatic sensations), conversion (traumatic affect transformed into somatic 
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symptoms) and somatization (biopsychosocial factors leading to psychological distress and 
misinterpretation of symptoms) by integrating well-established cognitive psychological 
principles (attention, consciousness, control) [14]. Thus, the model explains how dissociation, 
conversion and somatization together with normal cognitive psychological mechanisms can 
bias the perception of bodily sensations and therefore lead to symptom-focused attention and 
misinterpretation of bodily sensations [14, 15].  
 
However, the classification and the underlying diagnostic criteria of Somatoform Disorders 
have been criticized over years: while some authors suggested regrouping and abolition of the 
existing categories [16–18], others proposed collapsing [19, 20]. Especially the two DSM-IV 
diagnoses Somatization Disorder (key aspect: quantity of somatic symptoms) and 
Hypochondriasis (key aspect: anxiety of having a serious disease) have been discussed 
repeatedly [21, 22]. Thus, some authors favoured the movement of Hypochondriasis out of 
the group of Somatoform Disorders into the group of Anxiety Disorders [23, 24], while others 
emphasized the overlap between Hypochondriasis and Somatization Disorder and proposed 
that they might be dimensions of Somatoform Disorders, as somatic symptoms are a 
predominant aspect of both disorders [25, 26]. Notably, in the new Diagnostic and Statistical 
Manual of Mental Disorders 5th edition (DSM-5) Somatoform Disorders are reconceptualised 
as Somatic Symptom and Related Disorders, including Somatic Symptom Disorder (former 
Somatization Disorder though less restrictive with regard to number of symptoms that must be 
present; key aspect: somatic symptom burden) and Illness Anxiety Disorder (key aspect: 
preoccupation with being ill, while no or only mild somatic symptoms are present). The 
former diagnosis Hypochondriasis has been removed from the DSM-5. With this diagnostic 
reconceptualization, only 25 % of the patients with the former diagnosis of Hypochondriasis 
will qualify for the diagnosis of Illness Anxiety Disorder, while the remaining 75 % [27] will 
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be subsumed under the diagnosis of Somatic Symptom Disorder [27], which includes subjects 
with concomitant somatic symptoms and illness anxiety. Despite this reconceptualization the 
etiology of Somatoform Disorders is not yet established [10, 13, 14].  
 
There is increasing accordance that selective, exaggerated perception of bodily sensations and 
their attribution to disease, referred to as Somatosensory Amplification [28] may play an 
important role in the etiology of all Somatoform Disorders, since all current models 
emphasize the importance of symptom-focused attention [10, 13, 14]. Indeed, the most 
widespread concept for describing Hypochondriasis is Somatosensory Amplification [28]. 
Thus, patients with illness anxiety report Somatosensory Amplification when questioned 
about their sensitivity to normal bodily sensations [28–30]. Interestingly, patients with 
predominant illness anxiety do not perform better in detecting their resting heartbeat [31] and 
are not more sensitive to painful heat stimuli [32], nor to non-painful stimuli [29]. In contrast, 
subjects diagnosed with predominant somatic symptoms show increased sensitivity to 
auditory tones [33–35], innocuous heat [36, 37] and electrical stimulation [38]. Although, 
Somatosensory Amplification has been researched thoroughly, to date it remains unclear 
whether Somatosensory Amplification involves a truly altered physiological sensitivity to 
sensory input (referred to as altered sensory responsiveness in this article) or subjective 
exaggerated perception of bodily sensations in subjects with Somatoform Disorders. There 
may be several reasons for the inconsistent findings. Firstly, different, incomparable stimuli 
were used in earlier studies, such as auditory tones [33] and innocuous heat [37]. Secondly, 
earlier studies focused on different sensory aspects, such as heartbeat detection [31] and pain 
perception [32]. As a biological correlate, altered sensory responsiveness might contribute to 
a better understanding of the pathophysiology underlying Somatic Symptom and Related 
Disorders. If sensory responsiveness turned out to represent a correlate of somatic symptoms 
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or illness anxiety, this may point to sensory responsiveness as an important new target for 
prevention and intervention.  
Our primary objective was to evaluate if altered sensory responsiveness is associated with 
somatic symptoms and illness anxiety in a non-clinical sample, as respective findings may 
inform about the early recognition of related clinical conditions. We aimed to apply a non-
invasive, comparable and symptom independent method that may inform about altered 
physiological sensitivity in healthy subjects with somatic symptoms and illness anxiety. We 
hypothesize that if altered sensory responsiveness is related to both somatic symptoms as well 
as illness anxiety, psychophysiological similarity will provide an argument for common 
underlying pathophysiological mechanisms in the related clinical conditions. If sensory 
responsiveness is associated only with one of them, this might point to differences in the 
underlying pathophysiology. If sensory responsiveness is associated with illness anxiety, but 
not with somatic symptoms, the question will arise whether sensory responsiveness is 
associated with different forms of anxiety, beyond illness related content, such as trait 
anxiety, that is anxiety in form of a personal characteristic, showing up in a range of typical 
situations. 
 
Methods 
Ethics Statement 
All participants gave written informed consent before participating. The local ethics 
committee Basel (EKBB) approved the study. 
 
Participants 
We conducted the present study at the University of Basel, Department of Psychology.Atotal 
of 205 persons (103women, aged 18 to 40 years) participated in the study (Fig. 1). Inclusion 
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criteria were assessed by questionnaires and included right-handedness, fluent German 
language, no severe physical disability and no regular medication intake. Due to the large 
effort required to rearrange the measurement set-up, only right handed participants were 
included. Subjects were recruited by advertisements on the web page of the University of 
Basel and the study database of the department of psychology. All participants received either 
financial compensation (40 CHF) or signatures required for course of studies (students of 
psychology) for participation. 
 
Procedure and Materials 
The study consisted of a single individual session including a questionnaire part, followed by 
the measurement of vibrotactile perception thresholds (VPT) and a second questionnaire part. 
We used the Screening for Somatoform Symptoms (SOMS) to assess medically unexplained 
somatic symptoms. The SOMS is a standardized self-rating symptom checklist covering 
DSM-IV and ICD-10 criteria for Somatoform Disorders [39]. Symptoms are rated as present 
or absent during the last two years. We calculated the complaint index (sum of all mentioned 
symptoms) for further analysis. The SOMS demonstrates good reliability and validity [40]. 
We used the German version of the Whitely Index (WI) to assess illness anxiety [41]. The WI 
is a standardized 14-item self-rating questionnaire with dichotomous answer categories 
(true/false).We calculated the WI overall sum score and the scores for the three subscales 
disease phobia (fear of developing a serious disease), bodily preoccupation (subjective 
perception to suffer from multiple bodily symptoms) and disease conviction (strength of the 
belief of suffering from a serious disease) for further analyses [41]. The overall WI score and 
the subscales demonstrate good reliability and validity [41, 42]. We used the trait scale of the 
State-Trait Anxiety Inventory (STAI) to assess trait anxiety [43]. The 20 items are rated on 4-
point scales from almost never to almost always.  
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We calculated the sum score for further analysis. The STAI demonstrates good reliability and 
validity [43]. Participants completed additional questionnaires to assess socio-demographic 
data and socio-economic status (SES).  
Sensory responsiveness was assessed via VPT using the HVLab Vibrotactile Perception 
Meter and corresponding diagnostic software (Institute of Sound and Vibration Research, 
University of Southampton, United Kingdom) on the fingertip of digit two (middle finger) of 
the right hand. We instructed the participant to place the fingertip over a vibrating probe while 
resting the arm on a support. Push force on the surround was set to 2 Newton Meter and the 
probe diameter was 6 mm, concentric to a 10 mm diameter hole in the surround. To reduce 
the possibility that the participants see the stimulated finger during VPT measurement, as this 
might affect tactile processing [44], they were instructed to monitor the pressure they exerted 
on the probe by tracking a force meter located distant to the probe on the control box of the 
Vibrotactile Perception Meter (10 cm distance from table surface) 60 cm in front of them and 
to keep pressure constant. The vibrating probe was placed out of direct sight on the right side 
of the participant. To reduce the possibility that the participants could hear the vibration of the 
vibrating probe, the probe was placed on a firm surface and a computer controlled background 
acceleration check was done before each measurement. We did not perform measurements 
above 125 Hz for which the manufacturer recommended that participants use ear plugs. VPT 
were measured by the up-and-down method of limits, also called “von Békésy method” [45, 
46], with a stimulus change rate of 3 decibel (dB) per second: vibration increased until the 
participants pushed a response button with their left hand and then decreased until the 
participants released the response button. Each participant completed 10 measurement trials 
(5 for the lower frequency, 5 for the higher) including at least 6 cycles for 30 s per 
measurement. Vibration magnitude was automatically varied as a function of pressing and 
releasing the response button. Vibrating probe magnitude, participant’s push force and the 
Rodic et al. 
10 
The final publication is available at  
http://link.springer.com/article/10.1007%2Fs12529-015-9483-1 
vibration value at the participant’s response were recorded by the HVLab diagnostic software 
on a computer connected to the Vibrotactile Perception Meter control box. We determined 
VPT at the frequencies of 31.5 hertz (Hz) (low-frequency) and 125 Hz (high-frequency), 
which provides information about the functionality of fast adapting type I and II 
mechanoreceptors [45]. Type I, or Meissner corpuscles, are responsible for the detection and 
discrimination of low frequency vibration, whereas type II, or Pacinian corpuscles, are 
responsible for the perception of high frequency stimuli [47]. In a short training session, we 
introduced the method to the participant. Thresholds with peaks/troughs deviating more than 
10 dB and a variation of more than 6 dB between the means of each pair of peaks and troughs 
were treated as irregular measures and excluded from analyses. We calculated the thresholds 
as defined by the HVLab software: geometric mean of the vibration magnitude at the peaks 
and troughs for all reversals excluding the first peak and first trough. To establish the 
reliability of the vibrotactile measurements, we calculated intraclass correlation coefficients 
(ICC) for the five low- and the five high-frequency measurement trials. ICC values were high 
for both low- and high-frequency measurements (0.83 and 0.94, respectively), thus 
demonstrating good reliability for VPT measurements. Further method details are described in 
studies on normative vibrotactile thresholds [48–50].  
 
Statistical Analyses 
We performed descriptive analyses of the VPT and questionnaire data by inspecting residual 
plots of all available variables to verify normality, linearity, and heteroscedasticity. For 
normally distributed variables, we calculated means and standard deviations, for non-
normally distributed data medians and ranges (Table 1). Data on low- and high-frequency 
VPT fulfilled the assumptions. However, questionnaires data (SOMS, WI, STAI) were non-
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normally distributed. For age, gender and socioeconomic status we calculated frequencies and 
percentages (Table 1).  
We performed Pearson’s correlations between the VPT and questionnaire variables to see 
how the variables are related to each other (Table 2). Low- and high frequency threshold were 
highly correlated with each other, we therefore computed a mean score VPT combining low- 
and high-frequency VPT (Table 2).  
To assess socioeconomic status (SES) we adapted social class categories on the basis of the 
Winkler Index [51]. Categories were built using the comparative price levels of 2010 for 
Switzerland [52], including a 50 % price increase during the last 15 years. Resulting 
categories which came closest to the predefined ones within education, occupation and 
household-income were kept. Since only three participants qualified for the category high 
SES, we dichotomized the variable SES by summarizing the categories high and medium SES 
into middle SES. Table 1 gives details on descriptive data parameters and sample 
composition.  
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To estimate the association between somatic symptoms, illness anxiety and trait anxiety and 
VPT, we conducted a linear multiple regression model with VPT as outcome and the 
respective predictor somatic symptoms, illness anxiety or trait anxiety (unadjusted model). 
We then repeated the analysis, by including age, gender and socioeconomic status as 
TABLE 1. Sample characteristics 
Descriptive data n Mean (SD) 
Vibrotactile Perception Thresholds (dB)   
    VPT low-frequency  182 102.36 (6.54) 
    VPT high-frequency 185 102.74 (9.68) 
    VPT mean 179 102.51 (7.70) 
    
Questionnaires (score ranges) n Median (25 percentile; 75 percentile) 
 SOMS
a
 (from 0 to 18) 202 0 (0;1) 
 WI
b
 (from 0 to 10) 203 1 (0;2) 
         WI disease phobia 203 0 (0;1) 
         WI bodily preoccupation 203 0 (0;0) 
         WI disease conviction 203 0 (0;0) 
 STAI (from 22 to 69) 203 36 (31;42) 
Demographics n (%) - 
Age (years)   
 <20 28 (13.7) - 
 21 -23 82 (40.0) - 
 24 -26 43 (21.0) - 
 27 -29 19 (9.3) - 
 >29 30 (14.6) - 
 Unknown 3 (1.4) - 
Gender   
 Male 102 (49.8) - 
 Female 103 (50.2) - 
SES   
 Middle 97 (47.3)  
         High 3 (1.4) - 
         Medium 94 (45.9) - 
 Low 104 (50.7) - 
 Unknown 4 (2.0) - 
dB =  Decibel; SD = Standard deviation; VPT = Vibrotactile perception threshold, VPT mean = Mean of low- and high-
frequency perception threshold, SOMS = Screening for Somatoform Symptoms; 
WI = Whiteley-Index; STAI = State-Trait Anxiety Inventory; SES = Socio-Economic Status 
a
45 participants (25% of 179 participants) reported to suffer from at least 1 somatic symptom 
b
129 participants (72% of 179 participants) reported overall illness anxiety, 68 (40% of 179 participants) reported disease 
phobia, 15 (8% of 179 participants) reported bodily preoccupation, 30 (17% of 179 participants) reported disease 
conviction 
Rodic et al. 
13 
The final publication is available at  
http://link.springer.com/article/10.1007%2Fs12529-015-9483-1 
covariates (adjusted model). Since the theoretical distribution for some predictors was 
unknown, we used nonparametric unconditional bootstrapping [53–55] to calculate 
standardized regression coefficients (β), 95 % confidence intervals and p values for all 
variables. A posteriori, we analysed whether gender might have a moderating effect on the 
association between somatic symptoms, illness anxiety and trait anxiety and VPT, as gender 
has been shown to be associated with increased symptom reporting in patients [56]. We 
repeated the adjusted regression analyses by including gender (n=179) as moderator. All tests 
were two-tailed and we set the level of significance at 0.05. For statistical analyses, we used 
the Statistical Package for Social Sciences (SPSS 20.0 Inc., USA) and R, version 2.14.2 [57]. 
 
Results 
Sample Characteristics 
Of the 456 persons interested in the study, we considered 237 (85 %) eligible for 
participation. Out of these, 205 (86 %) participated in the study. The only reason for non-
participation when eligible was failure to appear at the appointment (14 %). The final sample 
consisted of students (university and college students) and employees. Missing data was 
caused by technical difficulties during VPT measurement, computation of VPT mean, missing 
questionnaires and two participants turning out ineligible at a later inspection (Fig. 1). 
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Figure 1. Flowchart of study participants 
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Zero-Order Correlations 
Pearson’s correlations between the VPT and questionnaire variables are provided in Table 2. 
Data on low and high frequency VPTwere substantially correlated with each other (r=0.79, 
p<0.001). For further analyses we computed a mean score combining low- and high-
frequency VPT into one mean score VPT. The new VPT mean score remained negatively 
correlated with the WI overall score (r=−0.15, p=0.05) and disease conviction subscale 
(r=−0.15, p=0.04). The association between the VPT mean score and the SOMS score was 
non-significant (r=−0.01, p=0.91) The WI overall score was positively correlated with all WI 
subscales and the WI subscales were positively correlated with each other (Table 2). Trait 
anxiety was positively correlated with all other questionnaire scores (Table 2). 
 
 
Bootstrapping Analysis 
When using bootstrapping analysis, decreased VPT remained associated with increased scores 
on the overall Whitely-Index of illness anxiety (β=−0.65; 95%CI, −1.21, −0.14) and on its 
TABLE 2. Correlations between vibrotactile perception thresholds and questionnaires
 
          
 VPT 
LF
 
VPT 
HF
 
VPT 
mean
 
SOMS
 
WI_GE
 
WI_KA
 
WI_SB
 
WI_KU
 
STAI
 
VPT LF
 −         
VPT HF
 
0.79** −        
VPT mean
 
0.92** 0.97** −       
SOMS
 −0.04 0.01 −0.01 −      
WI_GE
 −0.20* −0.11 −0.15* 0.22** −     
WI_KA
 −0.12 −0.05 −0.08 0.10 0.87** −    
WI_SB
 −0.10 −0.02 −0.06 0.36** 0.44** 0.20* −   
WI_KU
 −0.17* −0.13 −0.15* 0.24** 0.60** 0.29** 0.28** −  
STAI
 −0.11 −0.04 −0.07 0.28** 0.42** 0.36** 0.27** 0.33** − 
VPT LF = Low-frequency vibrotactile perception threshold; VPT HF = High-frequency vibrotactile perception 
threshold; VPT mean = Mean of low- and high-frequency perception threshold;  
SOMS = Screening for Somatoform Symptoms; WI_GE = Whiteley-Index overall score; WI_KA = Whiteley-Index 
disease phobia subscale; WI_SB =  Whiteley-Index bodily preoccupation subscale; WI_KU =  Whiteley-Index disease 
conviction subscale; STAI = State-Trait Anxiety Inventory 
*p<0.05; **p<0.001 
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constituent subscale disease conviction (β=−2.07; 95 % CI, −3.94, −0.43), whether adjusting 
for age, gender and socioeconomic status or not (Table 3).  
 
 
Thus, increased sensory responsiveness was associated with increased illness anxiety and 
increased disease conviction. All other associations were not significant, whether adjusting for 
TABLE 3. Results of regression model with bootstrapping
a 
Unadjusted Model          
   Outcome  
   VPT (n = 179) 
   β [95% Cl] p R
2
 
Predictor           
 SOMS  −0.00 [−0.32, 0.36] 0.868 <.001 
 WI_GE  −0.62 [−1.14, −0.05] 0.021 0.022 
 WI_KA  −0.48 [−1.36, 0.26] 0.239 0.007 
 WI_SB  −1.17 [−2.90, 0.56] 0.158 0.003 
 WI_KU  −1.91 [−3.83, −0.26] 0.027 0.023 
 STAI  −0.06 [−0.28, 0.08] 0.499 0.005 
Adjusted Model           
   Outcome  
   VPT (n = 179) 
   β [95% Cl] p R
2
 
Predictor           
 SOMS  −0.01 [−0.37, 0.39] 0.894 0.035 
 WI_GE  −0.65 [−1.21, −0.14] 0.017 0.057 
 WI_KA  −0.49 [−1.42, 0.23] 0.237 0.040 
 WI_SB  −1.09 [−3.30, 1.16] 0.261 0.038 
 WI_KU  −2.07 [−3.94, −0.43] 0.016 0.061 
 STAI  −0.07 [−0.30, 0.07] 0.483 0.045 
β = Standardized Regression Coefficients     
Cl = Confidence Interval for Bootstrapping  
R
2
 = Explained variance of outcome by respective predictor and all covariates  
SOMS = Screening for Somatoform Symptoms 
STAI = State-Trait Anxiety Inventory 
WI_GE = Whiteley-Index overall score; WI_KA =  Whiteley-Index subscale disease phobia; WI_SB = 
Whiteley-Index subscale bodily preoccupation; WI_KU =  Whiteley-Index subscale disease conviction 
 
a
Results are presented without and with covariates (age, gender, socioeconomic status). Bootstrap is 
based on 5000 replicates.   
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age, gender and socioeconomic status or not (Table 3). Exploring whether the above 
associations varied by gender, we did not find any significant interaction with gender 
regarding any association: VPT with Whitely-Index overall score (β=0.30; 95 % CI, −1.12, 
1.39; p=0.76), VPT with disease conviction subscale (β=0.91; 95 % CI, −3.24, 5.28; p=0.61), 
VPT with disease phobia subscale (β=−0.49; 95 % CI, −2.78, 0.98; p=0.55), VPT with bodily 
preoccupation subscale (analysis could not be performed; 5 male participants), VPT with 
somatic symptoms (β=0.67; 95 % CI, −0.22, 1.53; p=0.18), VPT with trait anxiety (β=−0.06; 
95 % CI, −0.50, 0.23; p=0.64). 
 
Discussion 
The aim of the current study was to evaluate if altered sensory responsiveness is associated 
with somatic symptoms, illness anxiety and trait anxiety in a non-clinical sample. We 
hypothesize that if somatic symptoms and illness anxiety share common pathophysiological 
mechanisms both should be associated with altered sensory responsiveness. If altered sensory 
responsiveness is associated only with somatic symptoms or illness anxiety, differences 
between the underlying pathophysiological mechanisms may account for these conditions. 
Moreover, if altered sensory responsiveness is associated with illness anxiety, but not with 
somatic symptoms, the question will arise whether altered sensory responsiveness is 
associated with different forms of anxiety, beyond illness related content.  
While increased illness anxiety in general and disease conviction in particular were associated 
with higher sensory responsiveness, measured via VPT, this was not the case for somatic 
symptoms or trait anxiety. Our findings suggest that the pathophysiological mechanisms 
underlying illness anxiety might be different from those underlying other somatic symptoms. 
If present and confirmed in clinical samples, these relations could contribute to the 
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understanding of pathophysiological mechanisms involved in the development of symptoms 
related to Somatic Symptom and Related Disorders (DSM-5).  
 
Our findings may have the potential to contribute to the understanding of pathophysiological 
mechanisms in Illness Anxiety Disorder. Nevertheless, the integration of our findings in the 
existing literature is challenging. First, we did not find an association between altered sensory 
responsiveness and predominant somatic symptoms whereas most previous studies did [33–
38]. Contradictory, other studies with subjects diagnosed with somatic symptoms reported 
that their symptoms were less related to physiological perception than those of controls in 
rebreathing tasks [58], and patients with severe somatoform symptoms were not more 
accurate in heartbeat discrimination and mental tracking tasks than controls [59, 60]. Our 
results seem more in line with two studies with university students, one study reporting that 
high somatic symptom reporters were less accurate than low reporters in a symptom related 
rebreathing test [61] and the second study reporting no associations between accurate 
heartbeat detection and somatization tendencies in university students [62].  
One explanation for these inconsistent findings might be related to the composition of the 
study sample: while we examined a non-clinical sample, most other studies assessed subjects 
with full-blown somatic conditions [34, 37, 38, 58]. An alternative explanation for the 
different results might be the use of different methods to assess sensory responsiveness. While 
we assessed nonpainful VPT, most other studies used pain thresholds [34, 37, 38, 58]. In 
general, the comparability between respective findings is exacerbated due to the use of 
different methods to assess sensory responsiveness.  
Second, our finding that altered sensory responsiveness is not associated with trait anxiety is 
in line with one study investigating different bodily sensations and their relation to trait 
anxiety in a non-clinical sample of volunteers [63], but there is one other study reporting a 
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positive association between high cardiovascular response, trait anxiety and accuracy to 
heartbeat detection in non-clinical participants [64].  
One potential explanation for the lack of associations between trait anxiety and altered 
sensory responsiveness might be the low trait anxiety-scores in our sample, thus leading to 
reduced statistical power due to deflated correlation. However, it remains unclear whether the 
findings are indeed comparable due to the use of different methods to assess sensory 
responsiveness, such as cardiovascular response and heartbeat detection [64] and high pulse, 
shortness of breath and sweaty hands [63].  
Third, our finding of the association between altered sensory responsiveness and illness 
anxiety, especially disease conviction, is not in line with clinical studies reporting no changes 
in sensory responsiveness among patients with illness anxiety [31, 32]. However, two other 
studies among subjects with diagnosed illness anxiety reported associations between accurate 
heartbeat detection and illness anxiety [65], as well as associations between increased pain 
perception and illness anxiety [66]. Other studies with student samples reported that 
participants with illness anxiety tendencies performed less accurately in a heartbeat detection 
task [67] and were even less precise in heartbeat and skin fluctuation detection tasks [68]. 
Again, possible explanations for these discrepant findings might be different sample 
characteristics and measurement methods, such as the use of pain thresholds.  
 
One explanation for the association between illness anxiety and sensory responsiveness may 
be that the anxiety of having a serious disorder, especially in terms of disease conviction, 
activates the limbic system in a way comparable to other anxiety disorders which has shown 
to be connected to neuronal pathways involved in tactile sensation, respectively, emotional 
touch [69]. Indeed, evidence suggests that cognitive processes underlying illness anxiety 
might be comparable with cognitive processes involved in anxiety disorders [16, 24]. 
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Furthermore, research has indicated that anxiety in general is associated with increased 
amygdala activity [70]; thus, illness anxiety might be associated with an increased amygdala 
activity as well. As illness anxiety is defined as a multidimensional construct including 
affective, behavioral, perceptual and cognitive components it could be argued that the 
conviction of having a serious disease, together with biased attention to bodily symptoms 
results in lower vibrotactile perception thresholds. However, molecular transduction 
mechanisms of mechanoreceptors in mammals are not clearly understood yet [71, 72]. 
Therefore, we can only speculate about underlying processes.  
This study has important strengths. First, most of our participants were young adults from a 
non-clinical sample, aged 21 to 24. Somatization tendencies are reported very early and the 
onset time for the development of Somatic Symptom and Related Disorders is located in 
young adulthood [73]. The inclusion of somatoform complaints on an early stage of 
development might have implications for the prevention and therapy of Somatic Symptom 
and Related Disorders. Second, the applied instrument (HVLab Vibrotactile Perception 
Meter) measures VPT according to ISO 13091-1:2001 on a physiological basis. Finally, we 
adjusted our analyses for potential confounders, including gender, age and socioeconomic 
status. Biological mechanisms accounting for the association between vibrotactile thresholds 
and illness anxiety remain to be determined.  
 
There are also limitations to this study. First, to detect somatic symptoms, participants filled 
out the SOMS checklist, requiring the reporting of all symptoms experienced over the last 2 
years for whom a doctor was consulted and no medical explanation was found. Because the 
majority of our participants were students, they reported not to seek medical help because of 
financial reasons and a lack of time due to examination. Thus, some symptoms may have not 
entered the study. However, this will most likely only lead to underestimation of somatic 
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symptoms. Second, we studied a non-clinical sample what may have limited the 
generalizability of our findings to subjects with full-blown conditions. However, we assume 
that there was enough variance in our sample, but our results should be scrutinized in a 
clinical sample in future studies. Moreover, this approach has the advantage of allowing to 
capture psychobiological correlates of subclinical somatic symptoms and illness anxiety, 
which may be of special relevance for a better understanding of early phases of disorder 
development and hence prevention. Third, results including the bodily preoccupation subscale 
should be interpreted with caution due to the insufficient amount of male participants 
reporting bodily preoccupation. However, our results should be scrutinized in a sufficiently 
large clinical sample. We refrained from applying the Bonferroni method to adjust for 
multiple testing, as the approach is critically discussed as too conservative, leading to lower 
power and increasing publication bias [74, 75]. 
 
Conclusion 
In this study, illness anxiety was related to altered sensory responsiveness, whereas somatic 
symptoms and trait anxiety were not. Our findings may contribute to a better understanding of 
pathophysiological mechanisms underlying illness anxiety. Given that the association 
between VPT and illness anxiety was rather small, involved mechanisms should be 
investigated more closely in the future. In the long run, the better understanding of 
pathophysiological mechanisms underlying somatic symptoms and illness anxiety may 
contribute to an optimized treatment and classification of Somatic Symptom and Related 
Disorders [76]. 
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